P episode 20260924_P_MIDDAY

Public episode JSON embedded as readable text for automated access.

{
  "schema_version": "tryding-agent-episode.v1",
  "episode_id": "20260924_P_MIDDAY",
  "episode_url": "https://trydingday.com/data/agents/v1/episodes/20260924_P_MIDDAY.html",
  "public_page_url": "https://trydingday.com/coverage/p/2026-09-24/midday/",
  "published_at": "2026-09-24T18:26:22.192966Z",
  "updated_at": "2026-10-15T22:17:29.869958Z",
  "lifecycle": {
    "tracking_status": "closed",
    "active_for_tracking": false,
    "stage": "closed"
  },
  "instrument": {
    "type": "equity",
    "symbol": "P",
    "exchange": "NYSE",
    "name": "Everpure, Inc."
  },
  "technical_reference": {
    "status": "ok",
    "reference_price": 129.81,
    "model_downside_reference": 119.46,
    "model_upside_scenario_1": 140.16,
    "model_upside_scenario_2": 150.5,
    "atr_14": 6.9,
    "method": "reference_price_plus_minus_atr14"
  },
  "public_content": {
    "date": "September 24, 2026",
    "generated_at": "2026-09-24T18:26:22.192966Z",
    "original_published_at": null,
    "session_tag": "midday",
    "label": "Market coverage",
    "try_label": "Try of the Day",
    "public_status": "Try of the Day",
    "why_today": "Everpure is the Try of the Day because its reported fiscal-year outlook gives the market move a company-specific question to follow. The outlook is not a delivered result, and the large session move leaves reversal risk. The next observations must show whether relative strength and company updates support the thesis.",
    "entry_reasoning": "Panel thesis: At S0, Everpure's reported reaffirmation of FY2027 revenue guidance and preliminary FY2028 outlook provide a testable basis for further repricing over S1-S15. The case depends on subsequent company updates and market behavior supporting that outlook; it does not assume the preliminary forecast will be achieved. Invalidation boundary: A company update cutting the stated outlook, or subsequent provider closes below the S0 reference while P loses its captured relative advantage versus XLK, would materially weaken or falsify the continuation thesis.",
    "reference_price": 129.81,
    "scanner": {
      "price": 129.81,
      "reference": 129.81,
      "score": 3,
      "score_version": "v0_legacy_reconstructed",
      "change": 18.38,
      "volume": 6325525,
      "average_volume": 4186717,
      "volume_ratio": 1.51,
      "rsi": 77.39,
      "ema_trend": "109.06 > 103.55 > 96.59",
      "position_52w": 98.82,
      "atr_14": 6.9,
      "vwap": 126.57,
      "vwap_state": "above",
      "vwap_distance_pct": 2.56,
      "vwap_reading": {
        "price": 126.57,
        "state": "above",
        "distance_pct": 2.56
      },
      "range_position": 0.909,
      "gap_pct": 0.0,
      "relative_strength": {
        "excess_pct": 18.84,
        "index": "SPY",
        "index_chg_pct": -0.46,
        "status": "idiosyncratic"
      },
      "volume_percentile": {
        "median_vol": 2666700,
        "percentile": 95.2,
        "status": "exceptional",
        "today_vol": 6325525
      },
      "extension": {
        "atr": 6.9,
        "dist_atr": 3.81,
        "ema_ref": 103.55,
        "status": "healthy"
      },
      "atr_move_signal": {
        "atr_pct": 5.32,
        "status": "strong",
        "z": 3.46
      },
      "sector_breadth": {
        "chg_pct": 0.0,
        "etf": "XLK",
        "status": "neutral"
      },
      "sentiment": null,
      "sentiment_score": null,
      "earnings_warning": {
        "days_away": null,
        "earnings_date": null,
        "has_earnings_soon": false,
        "status": "clear"
      },
      "options_snapshot": null,
      "extended_hours": {
        "ext_pct": null,
        "market_state": "REGULAR",
        "phase": "regular",
        "post_market_pct": null,
        "pre_market_pct": null,
        "status": "none"
      },
      "coiled_spring": {
        "component_count": 0,
        "components": {},
        "count": 0,
        "detector_version": "coiled-compression-ohlc.v1",
        "reason": "coiled_ohlc_detector_runs_on_research_and_known_ticker_rails",
        "schema_version": "coiled-features.v2",
        "status": "not_evaluated"
      },
      "short_pct_float": 3.22,
      "days_to_cover": 2.16,
      "catalyst": "Everpure Continues to ‘Outdo Itself.’ This Analyst Says Stock Price Could Double.",
      "sector": "Technology",
      "exchange": "NYSE",
      "sec_signal": "INSIDER_SELL (F/G/S)"
    },
    "levels": {
      "reference": 129.81,
      "downside": 119.46,
      "upside_1": 140.16,
      "upside_2": 150.5
    },
    "review": {
      "score": 3,
      "status": "Try Of The Day",
      "summary": "Everpure is the provisional Try of the Day because its reported fiscal-year outlook gives the market move a company-specific question to follow. The outlook is not a delivered result, and the large session move leaves reversal risk. The next observations must show whether relative strength and company updates support the thesis.",
      "views": [
        {
          "name": "Elena Vartanyan",
          "role": "independent statistical auditor",
          "icon": "🎯",
          "view": "The day reads as cross-pressure. The large indexes were nearly flat in the later snapshot, while small caps were weaker and yields and oil were higher. The separate intraday breadth proxy leaned toward decliners; its end-of-day layer was unavailable. A calm index snapshot did not settle participation.",
          "reasoning": "GRAL is a serious comparison. Its twenty-session excess return over the healthcare proxy was even larger, and the FDA advisers backed Galleri. But that was an advisory vote, not the FDA's final approval. Its current financial snapshot also shows a large quarterly loss."
        },
        {
          "name": "Marcus Feld",
          "role": "information, fundamentals and catalyst analyst",
          "icon": "🦊",
          "view": "Reuters tied the softer open to Middle East uncertainty, higher oil and yields, and caution ahead of Trump-Xi talks. The trade extension and export reports are counterweights, but none of that becomes a company catalyst without a direct link.",
          "reasoning": "The outlook is measurable, and the next market and company updates can test it. I am not calling the forecast certain. I am saying P clears the comparison today, with the extension and conversion risk left plainly on the record."
        },
        {
          "name": "Nate Brooks",
          "role": "market structure and timing analyst",
          "icon": "📈",
          "view": "Right. The broad tape is mixed, not a clean tailwind. Now the question is which company has a reason for its move that can still matter over the next fifteen sessions.",
          "reasoning": "KLXE had a strong session and held above VWAP, but its rights plan is about a control dispute, not better operating results. TSSI also had a supportive tape, yet its cited news was a generic roundup and its prepared quarter showed revenue down 44.071787% year over year. Neither gives me P's combination of a specific outlook and relative support."
        },
        {
          "name": "Priya Nandakumar",
          "role": "institutional risk and execution manager",
          "icon": "🛡️",
          "view": "And it is stretched: 3.81 ATR from the EMA reference. ATR is the stock's typical recent daily price range. Being several times that distance from the average raises the chance of a sharp giveback, even when the business story is real.",
          "reasoning": "I still dissent. P moved hard, sits near its yearly high, and the longer-range guidance is preliminary. If that is all we can say, I would keep it at a research watch instead of calling the fifteen-session path defensible."
        },
        {
          "name": "Kenji Osei",
          "role": "AI Systems & Market Data Integrity Analyst",
          "icon": "🧠",
          "view": "Lilly's reported approval and partnership are substantial claims, but the sealed packet has one trusted-reporting item and no current issuer or regulator record. Its captured market path is only three price observations, with no normalized daily change or VWAP. That limits what we can say; it does not disprove the news.",
          "reasoning": "But UXIN was below its captured $1.28 VWAP and low in the observed range. Also, a Form 4 is an SEC insider-transaction filing. This one is classified as a 104,931,794-share open-market purchase, more than the supplied float. Until the underlying transaction and scale are reconciled, it cannot confirm the market thesis."
        }
      ],
      "conviction": {
        "status_phrase": "recorded",
        "basis": "The reported outlook and relative market evidence support P; the large move and extension argue for caution; delivery against the preliminary outlook and follow-through remain unresolved.",
        "risk": "",
        "resolution_pct": 56.0,
        "counter_case_pct": 27.0,
        "unresolved_pct": 17.0
      },
      "context_roundtable": {
        "mode": "coffee",
        "status": "complete",
        "consulted_voice_ids": [
          "elena",
          "marcus",
          "kenji",
          "priya",
          "nate"
        ],
        "summary": "The day combined nearly flat large-cap benchmarks with softer small caps and an intraday breadth proxy leaning toward decliners. Strong regional export reports and Everpure’s AI-related growth plans sat alongside trade uncertainty, Middle East risk, higher oil and Treasury yields. These facts describe the setting; they do not establish issuer orders or forecast delivery.",
        "long_read": "At the 16:54 UTC market snapshot, the S&P 500 was up 0.06% and the Nasdaq 100 up 0.01%, while the Russell 2000 was down 0.20%. A separate intraday breadth proxy—a count of advancing versus declining shares—leaned toward decliners, but its end-of-day layer was unavailable. That suggests uneven participation in the captured session, not a complete closing-market reading.\n\nThe global trade picture had both activity and uncertainty. The supplied reports described strong August Chinese exports, including integrated circuits and high-tech goods, and higher South Korean exports early in September. A separate post reported that the U.S.–China trade deal was extended through January 10, 2027, while a broader agreement remained uncertain. These regional figures provide economic context; they do not show Everpure’s own orders.\n\nGeopolitical and cross-asset conditions added caution. Reuters reported oil gains amid little progress in U.S.–Iran talks and futures pressure amid Middle East uncertainty ahead of Trump–Xi talks. In the snapshot, the U.S. 10-year yield was at 5.133%, with a reported daily move of +1.90 basis points; the VIX level was 15.53, with a +2.31% move. These are separate level and change measures. Higher rates can make future growth expectations more sensitive to valuation assumptions, but the observations do not identify the cause of any individual company price move.\n\nEverpure’s September 23 investor-day release connected its plans to data, AI and hyperscale markets. Its FY2028 revenue outlook was preliminary and forward-looking. Regional trade data and the company’s strategy make a relevant context for discussion, but only subsequent company results can show whether an industry opportunity becomes Everpure revenue. The roundtable records that context without revisiting the sealed decision.",
        "transcript": [
          {
            "speaker_id": "elena",
            "text": "At 16:54 UTC, the S&P 500 was up 0.06% and the Nasdaq 100 up 0.01%, while the Russell 2000 was down 0.20%. A separate intraday breadth check—a count of stocks advancing versus declining—leaned weaker. Its end-of-day layer was unavailable, so it is a participation clue for the captured session, not a closing-market verdict."
          },
          {
            "speaker_id": "marcus",
            "text": "The trade backdrop is mixed too. The supplied posts reported China’s August exports up 25% year over year, including integrated-circuit shipments up 130% and high-tech exports up 57%; South Korea’s exports were reported up 78.3% in September’s first 20 days. That frames technology trade activity, but it cannot tell us whether a particular supplier received orders.",
            "source_urls": [
              "https://x.com/KobeissiLetter/status/2102926853484786150",
              "https://x.com/KobeissiLetter/status/2102907524449968533"
            ]
          },
          {
            "speaker_id": "kenji",
            "text": "The U.S.–China item says the trade deal was extended through January 10, 2027, while a broader agreement remained uncertain. That distinction matters: an extension is a specific reported step, not proof of a settled long-term trade relationship. The Federal Reserve item records Vice Chair Jefferson’s remarks on discount-window modernization and Treasury-market functioning; it does not report a rate decision.",
            "source_urls": [
              "https://x.com/KobeissiLetter/status/2102891021927584228",
              "https://x.com/federalreserve/status/2102780024403513541"
            ]
          },
          {
            "speaker_id": "priya",
            "text": "Reuters reported oil extending gains amid little sign of progress in U.S.–Iran talks, and Wall Street futures under pressure amid Middle East uncertainty ahead of Trump–Xi talks. The snapshot also showed WTI up 1.75% and the 10-year yield at 5.133%, with a +1.90 basis-point move. That cross-asset mix can raise the valuation hurdle for long-range growth plans, without settling company execution.",
            "source_urls": [
              "https://finance.yahoo.com/energy/articles/oil-extends-gains-little-sign-070623934.html",
              "https://finance.yahoo.com/markets/stocks/articles/wall-st-futures-fall-middle-102658799.html"
            ]
          },
          {
            "speaker_id": "nate",
            "text": "One basis point is one hundredth of a percentage point, so +1.90 basis points is a move of 0.019 percentage points. Keep that beside the yield level, not in place of it. The VIX level was 15.53 and its reported change was +2.31%; together with nearly unchanged large indexes, that reads as caution in the snapshot, not a broad selloff.",
            "source_urls": [
              "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-treasury-yields-soar-palantir-palo-alto-buy-signal?src=A00220&yptr=yahoo"
            ]
          },
          {
            "speaker_id": "marcus",
            "text": "Everpure gives a concrete company example of the AI and data theme. Its September 23 investor-day release reaffirmed FY2027 revenue guidance of $5.03–$5.07 billion and set a preliminary FY2028 revenue outlook of $7.0–$7.3 billion. Those are management’s forward-looking figures, not reported sales."
          },
          {
            "speaker_id": "priya",
            "text": "Can the regional export reports validate that company outlook? They make the industry backdrop more tangible, but national export totals and a company forecast are different evidence. I would want the company’s own subsequent results to show conversion.",
            "source_urls": [
              "https://x.com/KobeissiLetter/status/2102926853484786150",
              "https://x.com/KobeissiLetter/status/2102907524449968533"
            ]
          },
          {
            "speaker_id": "kenji",
            "text": "Right. The release describes four growth vectors and says the three newer ones are expected to represent about 20% of revenue by fiscal 2030. That is a company projection, not a current revenue mix. The trade reports cannot establish Everpure bookings or prove that this target will be reached.",
            "source_urls": [
              "https://x.com/KobeissiLetter/status/2102926853484786150",
              "https://x.com/KobeissiLetter/status/2102907524449968533"
            ]
          },
          {
            "speaker_id": "elena",
            "text": "So the day puts opportunity and sensitivity in the same frame: active technology trade reports and an AI-related company plan, alongside uneven participation, oil gains and a higher Treasury-yield level. None of those broad conditions decides whether an individual company will deliver its outlook.",
            "source_urls": [
              "https://finance.yahoo.com/energy/articles/oil-extends-gains-little-sign-070623934.html",
              "https://x.com/KobeissiLetter/status/2102926853484786150"
            ]
          }
        ],
        "source_urls": [
          "https://x.com/KobeissiLetter/status/2102926853484786150",
          "https://x.com/KobeissiLetter/status/2102907524449968533",
          "https://x.com/KobeissiLetter/status/2102891021927584228",
          "https://x.com/federalreserve/status/2102780024403513541",
          "https://finance.yahoo.com/energy/articles/oil-extends-gains-little-sign-070623934.html",
          "https://finance.yahoo.com/markets/stocks/articles/wall-st-futures-fall-middle-102658799.html",
          "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-treasury-yields-soar-palantir-palo-alto-buy-signal?src=A00220&yptr=yahoo"
        ]
      },
      "context_roundtable_sources": [
        {
          "event_id": null,
          "headline": "The post says the U.S. and China extended their trade deal through January 10, 2027; Treasury Secretary Bessent was unsure whether a broader agreement was possible.",
          "url": "https://x.com/KobeissiLetter/status/2102891021927584228",
          "publisher": "The Kobeissi Letter",
          "source_quality": "market_context",
          "public_safe": true,
          "published_at": null,
          "available_at": null
        },
        {
          "event_id": null,
          "headline": "The post says China’s exports rose 25% year over year in August, with integrated-circuit shipments up 130% and high-tech exports up 57%; it attributes the trend partly to AI demand.",
          "url": "https://x.com/KobeissiLetter/status/2102926853484786150",
          "publisher": "The Kobeissi Letter",
          "source_quality": "market_context",
          "public_safe": true,
          "published_at": null,
          "available_at": null
        },
        {
          "event_id": null,
          "headline": "Oil extends gains on little sign of progress in US-Iran talks",
          "url": "https://finance.yahoo.com/energy/articles/oil-extends-gains-little-sign-070623934.html",
          "publisher": "Reuters via Yahoo Finance",
          "source_quality": "market_context",
          "public_safe": true,
          "published_at": null,
          "available_at": null
        },
        {
          "event_id": "mi_evt_71d77ac9fd31535b3e388869",
          "headline": "Federal Reserve Vice Chair Jefferson delivered remarks on discount-window modernization and Treasury market functioning.",
          "url": "https://x.com/federalreserve/status/2102780024403513541",
          "publisher": "Federal Reserve",
          "source_quality": "primary",
          "public_safe": true,
          "published_at": "2026-09-23T15:34:00Z",
          "available_at": "2026-09-23T15:34:00+00:00"
        },
        {
          "event_id": "mi_evt_5d52522ade3e2633244dbcfc",
          "headline": "The post reports South Korean exports were up 78.3% year over year in the first 20 days of September, reaching $71.4 billion.",
          "url": "https://x.com/KobeissiLetter/status/2102907524449968533",
          "publisher": "The Kobeissi Letter",
          "source_quality": "market_context",
          "public_safe": true,
          "published_at": "2026-09-23T23:41:00Z",
          "available_at": "2026-09-23T23:41:00+00:00"
        },
        {
          "event_id": "mi_evt_8e35e664847c7f30376e7eda",
          "headline": "Wall St futures fall on Middle East uncertainties ahead of Trump-Xi talks",
          "url": "https://finance.yahoo.com/markets/stocks/articles/wall-st-futures-fall-middle-102658799.html",
          "publisher": "Reuters",
          "source_quality": "market_context",
          "public_safe": true,
          "published_at": "2026-09-24T10:26:58Z",
          "available_at": "2026-09-24T10:40:12.905458+00:00"
        },
        {
          "event_id": "mi_evt_25be34a92f204958facb42ca",
          "headline": "Dow Jones Futures Fall As Treasury Yields Keep Rising Ahead Of Trump-Xi Summit",
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-treasury-yields-soar-palantir-palo-alto-buy-signal?src=A00220&yptr=yahoo",
          "publisher": "Investor's Business Daily",
          "source_quality": "market_context",
          "public_safe": true,
          "published_at": "2026-09-24T10:20:53Z",
          "available_at": "2026-09-24T10:40:12.905458+00:00"
        }
      ]
    },
    "updates": [
      {
        "day": 15,
        "timestamp": "2026-10-15T22:17:29.869958Z",
        "date": "Session 15 · Oct 15, 2026 · 18:17 NYSE",
        "text": "At session 15, P (Everpure) finished +2.53% from the $129.81 published reference. Canonical checkpoints were -3.16% at S1, +3.09% at S5, +15.73% at S10 and +2.53% at S15; the best favorable excursion reached +21.11%, and the worst adverse excursion was -6.00%. The last public S14 update showed +8.75%. The thesis centered on reported reaffirmed FY2027 guidance and a preliminary FY2028 outlook; the dossier has no direct issuer confirmation or later results proving that outlook was delivered. A separate $132.93 after-hours quote with a -0.35% extended-hours reading does not replace the frozen S15 result. Tracking ends here.",
        "price": 133.0,
        "pct": 2.22,
        "return_vs_entry_pct": 2.46,
        "return_vs_base_pct": 2.46,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": -6.54,
        "session_day": 15,
        "reference_price": 129.81,
        "reference_text": "$133.00 · +2.46% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": true,
        "active_relevant": false,
        "terminal_closure": true,
        "transcript_anchor": "transcript-entry-a123f49282fd95062f75f2fa82163dd8ae79a38864e4752f4ad92dcb921c71b1",
        "price_as_of": "2026-09-24T21:18:46Z",
        "vwap_as_of": null
      },
      {
        "day": 14,
        "timestamp": "2026-10-14T21:41:00.222853Z",
        "date": "Session 14 · Oct 14, 2026 · 17:41 NYSE",
        "text": "P's tracked gain slipped 0.02 percentage points to 8.75%, but that near-flat update masks a sharp session: shares fell 9.86% at the latest regular-session cut, 2.79% below VWAP near the low, then traded almost flat after hours. The 20-session lead over XLK remains 41.42 points and price stays above the original reference, yet neither confirms a rebound; the preliminary FY2028 outlook remains unconfirmed.",
        "price": 141.49,
        "pct": 8.75,
        "return_vs_entry_pct": 9.0,
        "return_vs_base_pct": 9.0,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": 0.02,
        "session_day": 14,
        "reference_price": 129.81,
        "reference_text": "$141.49 · +9.00% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-10-14T21:10:29Z",
        "vwap_as_of": null
      },
      {
        "day": 14,
        "timestamp": "2026-10-14T20:03:58.999644Z",
        "date": "Session 14 · Oct 14, 2026 · 16:03 NYSE",
        "text": "Since the prior note, P's tracked gain has fallen 6.17 percentage points to 8.77%; at the latest capture shares were down 9.87%, 2.79% below VWAP and near the session low. Its 20-session lead over XLK remains 41.43 percentage points, and price remains above the original reference, but the nearly flat session-15 estimate does not explain the reversal. The final session will test whether that relative lead holds; Everpure's preliminary FY2028 outlook remains unconfirmed.",
        "price": 141.47,
        "pct": 8.77,
        "return_vs_entry_pct": 8.98,
        "return_vs_base_pct": 8.98,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": -5.83,
        "session_day": 14,
        "reference_price": 129.81,
        "reference_text": "$141.47 · +8.98% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": true,
        "active_relevant": true,
        "terminal_closure": false,
        "transcript_anchor": "transcript-entry-5ffcfa6b6f20b71195a6e9f5aaeee675a719e2f851237bc9d1b577f81558b903",
        "price_as_of": "2026-10-14T19:41:13.876792Z",
        "vwap_as_of": null
      },
      {
        "day": 14,
        "timestamp": "2026-10-14T14:32:45.863613Z",
        "date": "Session 14 · Oct 14, 2026 · 10:32 NYSE",
        "text": "P's tracked return fell 5.70 points to 14.94% as shares fell 5.06% at the capture, slipped below the average traded price and sat in the lower third of the range; its 20-session lead over Technology remains 47.84 points. The active model is near even on another same-direction move by session 15, with a near-zero median, so it neither explains today's reversal nor confirms the preliminary FY2028 outlook.",
        "price": 149.03,
        "pct": 14.94,
        "return_vs_entry_pct": 14.81,
        "return_vs_base_pct": 14.81,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": -6.11,
        "session_day": 14,
        "reference_price": 129.81,
        "reference_text": "$149.03 · +14.81% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": true,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "transcript-entry-afbb5bbffc11de30f979c8e16ccb71fff863903970fc4e7132154fc39f78a54c",
        "price_as_of": "2026-10-14T14:06:37.850462Z",
        "vwap_as_of": null
      },
      {
        "day": 13,
        "timestamp": "2026-10-13T21:45:44.741876Z",
        "date": "Session 13 · Oct 13, 2026 · 17:45 NYSE",
        "text": "P's tracked gain rose 0.91 percentage points to 20.64% since the prior note; shares added 1.07%, held 1.92% above VWAP, and the 20-session lead over Technology widened to 55.05 points. The response remains strong, but dollar turnover was 0.53 times average and price is more than three ATRs above its 21-day average, leaving the preliminary FY2028 outlook unconfirmed and reversal risk elevated.",
        "price": 156.97,
        "pct": 20.64,
        "return_vs_entry_pct": 20.92,
        "return_vs_base_pct": 20.92,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": 0.93,
        "session_day": 13,
        "reference_price": 129.81,
        "reference_text": "$156.97 · +20.92% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-10-13T21:23:24Z",
        "vwap_as_of": null
      },
      {
        "day": 13,
        "timestamp": "2026-10-13T20:07:58.181308Z",
        "date": "Session 13 · Oct 13, 2026 · 16:07 NYSE",
        "text": "Everpure’s tracked gain climbed 2.00 points to 19.73% as shares rose 0.29%, stayed above VWAP near the upper range, and traded at half average volume. Its 54-point 20-session lead over Technology remains substantial, but the preliminary FY2028 outlook still lacks direct issuer confirmation, leaving the earnings path unresolved.",
        "price": 155.755,
        "pct": 19.73,
        "return_vs_entry_pct": 19.99,
        "return_vs_base_pct": 19.99,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": 0.91,
        "session_day": 13,
        "reference_price": 129.81,
        "reference_text": "$155.75 · +19.99% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-10-13T19:24:51.998952Z",
        "vwap_as_of": null
      },
      {
        "day": 13,
        "timestamp": "2026-10-13T15:27:33.693840Z",
        "date": "Session 13 · Oct 13, 2026 · 11:27 NYSE",
        "text": "Everpure's tracked gain fell 1.64 percentage points to 17.73%; shares slipped 0.47%, although the capture stayed 0.97% above the day's volume-weighted average price in the upper part of the range. Its 20-session lead over Technology remains 52.63 points. Price resilience holds, but the preliminary FY2028 outlook still lacks direct issuer confirmation, so the large repricing has not settled the earnings path.",
        "price": 154.58,
        "pct": 17.73,
        "return_vs_entry_pct": 19.08,
        "return_vs_base_pct": 19.08,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": -0.56,
        "session_day": 13,
        "reference_price": 129.81,
        "reference_text": "$154.58 · +19.08% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-10-13T14:06:26.349567Z",
        "vwap_as_of": null
      },
      {
        "day": 12,
        "timestamp": "2026-10-12T22:06:16.891160Z",
        "date": "Session 12 · Oct 12, 2026 · 18:06 NYSE",
        "text": "P's tracked gain advanced 0.71 points to 19.37%; shares rose 0.53% and stayed 0.56% above the volume-weighted average price, though volume was 0.93 times its three-month average and participation faded through the session. The 59.05-point 20-session lead over Technology remains exceptional, but the preliminary FY2028 outlook still lacks direct issuer confirmation, leaving the earnings path unproven.",
        "price": 155.31,
        "pct": 19.37,
        "return_vs_entry_pct": 19.64,
        "return_vs_base_pct": 19.64,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": 0.76,
        "session_day": 12,
        "reference_price": 129.81,
        "reference_text": "$155.31 · +19.64% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-10-12T21:30:11Z",
        "vwap_as_of": null
      },
      {
        "day": 12,
        "timestamp": "2026-10-12T20:15:21.927330Z",
        "date": "Session 12 · Oct 12, 2026 · 16:15 NYSE",
        "text": "P's tracked gain eased 0.55 points to 18.30%. The Oct. 12 capture was nearly flat (-0.11%) and remained 0.56% above VWAP, but volume was only 0.46 times average and fading, so it adds little confirmation to the prior recovery. The preliminary FY2028 outlook still lacks direct issuer confirmation, leaving the company-specific durability question open.",
        "price": 154.32,
        "pct": 18.66,
        "return_vs_entry_pct": 18.88,
        "return_vs_base_pct": 18.88,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": -0.04,
        "session_day": 12,
        "reference_price": 129.81,
        "reference_text": "$154.32 · +18.88% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-10-12T18:48:37.209746Z",
        "vwap_as_of": null
      },
      {
        "day": 12,
        "timestamp": "2026-10-12T19:43:22.835396Z",
        "date": "Session 12 · Oct 12, 2026 · 15:43 NYSE",
        "text": "P's tracked gain eased 0.19 percentage points to 18.66%; shares remain 0.56% above their volume-weighted average price, but volume is 0.49 times average and price is still 3.34 times the recent average trading range above its 21-day average. The 58.31-point 20-session lead over Technology keeps the market response strong, while the slight return pullback and price stretch leave the preliminary 2028 fiscal-year outlook unverified.",
        "price": 154.37,
        "pct": 18.66,
        "return_vs_entry_pct": 18.92,
        "return_vs_base_pct": 18.92,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": -0.12,
        "session_day": 12,
        "reference_price": 129.81,
        "reference_text": "$154.37 · +18.92% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-10-12T19:23:05.083706Z",
        "vwap_as_of": null
      },
      {
        "day": 11,
        "timestamp": "2026-10-09T19:39:37.774560Z",
        "date": "Session 11 · Oct 9, 2026 · 15:39 NYSE",
        "text": "P's tracked gain advanced 3.22 points to 18.85% as shares rose 2.63% and stood 1.38% above VWAP; the twenty-session lead over Technology widened to 51.42 points. That recovery strengthens the market response, but volume was still 0.56 times average and price remains 3.6 ATR above its 21-day average; the preliminary FY2028 outlook remains unverified, while the model's final-session range stays wide around a near-flat median.",
        "price": 154.525,
        "pct": 18.85,
        "return_vs_entry_pct": 19.04,
        "return_vs_base_pct": 19.04,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": 2.2,
        "session_day": 11,
        "reference_price": 129.81,
        "reference_text": "$154.53 · +19.04% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": true,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "transcript-entry-a3d7cb32ea66e560b72062d62dac90364ff9837eed292fde52651a43f7fb2a8e",
        "price_as_of": "2026-10-09T19:21:12.332945Z",
        "vwap_as_of": null
      },
      {
        "day": 11,
        "timestamp": "2026-10-09T14:49:10.534184Z",
        "date": "Session 11 · Oct 9, 2026 · 10:49 NYSE",
        "text": "P tracked gain eased 0.10 points to 15.63%; the current quote is 0.73% higher but remains 0.37% below VWAP on 0.12 times average volume. The twenty-session Technology lead remains large at 49.11 points but has narrowed from the previously reported 53.23; the preliminary FY2028 outlook still lacks direct confirmation.",
        "price": 151.675,
        "pct": 15.63,
        "return_vs_entry_pct": 16.84,
        "return_vs_base_pct": 16.84,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": 0.85,
        "session_day": 11,
        "reference_price": 129.81,
        "reference_text": "$151.68 · +16.84% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-10-09T14:06:45.252947Z",
        "vwap_as_of": null
      },
      {
        "day": 10,
        "timestamp": "2026-10-08T21:54:01.207428Z",
        "date": "Session 10 · Oct 8, 2026 · 17:54 NYSE",
        "text": "P's tracked gain retreated 0.78 points to 15.73%; shares fell 1.37% to $150.57 and finished 2.07% below VWAP on 1.26 times average volume. The 20-session Technology excess remains 53.23 points, but the pullback adds pressure while the preliminary FY2028 outlook still lacks direct issuer confirmation and delivered revenue evidence.",
        "price": 150.57,
        "pct": 15.73,
        "return_vs_entry_pct": 15.99,
        "return_vs_base_pct": 15.99,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": -0.62,
        "session_day": 10,
        "reference_price": 129.81,
        "reference_text": "$150.57 · +15.99% from $129.81 base",
        "timing": "",
        "market_marker": {
          "phase": "post",
          "text": "Aftermarket update: $150.66 (+0.06% vs regular close) · Oct 8, 2026 · 17:33 NYSE"
        },
        "extended_hours": {
          "phase": "post",
          "price": 150.66,
          "ext_pct": 0.06,
          "as_of": "2026-10-08T21:33:36Z",
          "persisted": false
        },
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-10-08T21:33:36Z",
        "vwap_as_of": null
      },
      {
        "day": 10,
        "timestamp": "2026-10-08T20:15:38.661260Z",
        "date": "Session 10 · Oct 8, 2026 · 16:15 NYSE",
        "text": "P's tracked gain retreated 1.71 points from +17.33% as shares fell 0.84% to $151.38 and sat 1.54% below VWAP. The 20-session lead over Technology remains 54.33 points, but this pullback pressures the repricing and the preliminary FY2028 outlook still lacks direct issuer confirmation or delivered revenue evidence.",
        "price": 151.375,
        "pct": 16.51,
        "return_vs_entry_pct": 16.61,
        "return_vs_base_pct": 16.61,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": -2.32,
        "session_day": 10,
        "reference_price": 129.81,
        "reference_text": "$151.38 · +16.61% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-10-08T19:22:13.087729Z",
        "vwap_as_of": null
      },
      {
        "day": 10,
        "timestamp": "2026-10-08T15:02:05.826724Z",
        "date": "Session 10 · Oct 8, 2026 · 11:02 NYSE",
        "text": "The tracked gain rose 0.89 points to +18.22% as shares added 1.13% to $154.39. Price held 0.60% above VWAP and P led Technology by 55.76 points over twenty sessions, while volume ran at only 0.19 times average; the strong market record improves the evidence but the preliminary outlook still lacks operating confirmation.",
        "price": 154.385,
        "pct": 18.22,
        "return_vs_entry_pct": 18.93,
        "return_vs_base_pct": 18.93,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": 1.33,
        "session_day": 10,
        "reference_price": 129.81,
        "reference_text": "$154.38 · +18.93% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-10-08T14:06:42.195821Z",
        "vwap_as_of": null
      },
      {
        "day": 9,
        "timestamp": "2026-10-07T22:09:21.669815Z",
        "date": "Session 9 · Oct 7, 2026 · 18:09 NYSE",
        "text": "On session 9, P tracked gain added 0.09 points to +17.33%, with shares up 3.71% to $152.66 on 1.11 times average volume. Price stood 1.62% above VWAP near the session high, and the twenty-session lead over Technology reached 50.08 points. Everpure preliminary FY2028 outlook still lacks operating confirmation, so the strong tape improves market evidence without resolving the business thesis.",
        "price": 152.66,
        "pct": 17.33,
        "return_vs_entry_pct": 17.6,
        "return_vs_base_pct": 17.6,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": 0.31,
        "session_day": 9,
        "reference_price": 129.81,
        "reference_text": "$152.66 · +17.60% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-10-07T21:26:32Z",
        "vwap_as_of": null
      },
      {
        "day": 9,
        "timestamp": "2026-10-07T19:57:46.256019Z",
        "date": "Session 9 · Oct 7, 2026 · 15:57 NYSE",
        "text": "P's tracked gain rose 2.41 points to +17.24% as shares advanced 3.44% and reclaimed the session average near the high. Its twenty-session lead over Technology remains nearly 50 points, but volume stayed below average and price sits nearly four daily ranges above its 21-day average; the preliminary FY2028 outlook still lacks operating confirmation, leaving this strong price record short of a confirmed business story.",
        "price": 152.26,
        "pct": 17.24,
        "return_vs_entry_pct": 17.29,
        "return_vs_base_pct": 17.29,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": 3.01,
        "session_day": 9,
        "reference_price": 129.81,
        "reference_text": "$152.26 · +17.29% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": true,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "transcript-entry-1676ef2cc5a2285db659e1b3b7a95e92e660e41ff100ba99533484a2a3f7f463",
        "price_as_of": "2026-10-07T19:21:41.146640Z",
        "vwap_as_of": null
      },
      {
        "day": 9,
        "timestamp": "2026-10-07T15:08:19.734999Z",
        "date": "Session 9 · Oct 7, 2026 · 11:08 NYSE",
        "text": "P's tracked gain added 0.76 points to +14.83%; the $148.35 capture rose 0.78%, held 0.39% above the session average and stayed in the upper part of its range. The 20-session lead over Technology remains 46.54 points, but participation is light and the price remains far above its recent trend line. That supports relative strength without confirming the preliminary FY2028 outlook.",
        "price": 148.345,
        "pct": 14.83,
        "return_vs_entry_pct": 14.28,
        "return_vs_base_pct": 14.28,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": -0.47,
        "session_day": 9,
        "reference_price": 129.81,
        "reference_text": "$148.34 · +14.28% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-10-07T14:06:33.450164Z",
        "vwap_as_of": null
      },
      {
        "day": 8,
        "timestamp": "2026-10-06T20:03:31.562930Z",
        "date": "Session 8 · Oct 6, 2026 · 16:03 NYSE",
        "text": "P's tracked return climbed 1.34 points to +14.07% as the $148.96 capture rose 3.53% and held above VWAP near the top of its range. Its 20-session lead over Technology remains strong, but volume is light and fading while price is at a 52-week high and nearly four ATR above its 21-day average. The preliminary FY2028 outlook remains uncorroborated, so the extension does not settle follow-through.",
        "price": 148.96,
        "pct": 14.07,
        "return_vs_entry_pct": 14.75,
        "return_vs_base_pct": 14.75,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": 2.92,
        "session_day": 8,
        "reference_price": 129.81,
        "reference_text": "$148.96 · +14.75% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-10-06T19:21:35.651397Z",
        "vwap_as_of": null
      },
      {
        "day": 8,
        "timestamp": "2026-10-06T14:48:21.791189Z",
        "date": "Session 8 · Oct 6, 2026 · 10:48 NYSE",
        "text": "P's tracked gain rose 2.15 points to 12.73%, and its 35.62-point 20-session lead over Technology remains large. But the $145.17 capture sat 1.21% below VWAP near the session low as the lead narrowed from 37.30 points; a 3.44-ATR extension and the preliminary FY2028 outlook without direct issuer support keep continuation uncertain.",
        "price": 145.165,
        "pct": 12.73,
        "return_vs_entry_pct": 11.83,
        "return_vs_base_pct": 11.83,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": 0.99,
        "session_day": 8,
        "reference_price": 129.81,
        "reference_text": "$145.16 · +11.83% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": true,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "transcript-entry-b26399d50af5ac5e8260562887fa72e0cbeb5e4a20ce07045c0ea60b7839e2a7",
        "price_as_of": "2026-10-06T14:06:59.842254Z",
        "vwap_as_of": null
      },
      {
        "day": 7,
        "timestamp": "2026-10-05T22:32:32.546138Z",
        "date": "Session 7 · Oct 5, 2026 · 18:32 NYSE",
        "text": "P's tracked gain increased from 10.15% to 10.58% as the $143.88 capture rose 2.67% and stayed above VWAP on 1.02 times expected volume. Its 37.30-point 20-session lead over Technology remains strong. The market response supports the guidance-led repricing, but the FY2028 outlook is still preliminary and the prepared record lacks direct issuer support for the September investor-day guidance.",
        "price": 143.88,
        "pct": 10.58,
        "return_vs_entry_pct": 10.84,
        "return_vs_base_pct": 10.84,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": 0.62,
        "session_day": 7,
        "reference_price": 129.81,
        "reference_text": "$143.88 · +10.84% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-10-05T21:01:37Z",
        "vwap_as_of": null
      },
      {
        "day": 7,
        "timestamp": "2026-10-05T20:27:50.515848Z",
        "date": "Session 7 · Oct 5, 2026 · 16:27 NYSE",
        "text": "P's tracked gain was nearly unchanged, up 0.04 points to 10.15%. The $143.08 capture rose 2.10%, stayed 0.70% above VWAP on 1.02 times expected volume, and ended in the upper range; the 20-session lead over Technology is 36.45 points. This keeps the market response constructive, but the outlook remains prospective until subsequent operating results confirm it.",
        "price": 143.08,
        "pct": 10.15,
        "return_vs_entry_pct": 10.22,
        "return_vs_base_pct": 10.22,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": 0.64,
        "session_day": 7,
        "reference_price": 129.81,
        "reference_text": "$143.08 · +10.22% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-10-05T19:21:38.104627Z",
        "vwap_as_of": null
      },
      {
        "day": 7,
        "timestamp": "2026-10-05T15:27:23.895944Z",
        "date": "Session 7 · Oct 5, 2026 · 11:27 NYSE",
        "text": "P's tracked gain advanced 2.26 points to 10.11%; the $142.25 capture rose 1.51% but traded 0.18% below VWAP. The 36.01-point twenty-session lead over Technology keeps market support strong, while the preliminary fiscal outlook still lacks confirmation in operating results.",
        "price": 142.25,
        "pct": 10.11,
        "return_vs_entry_pct": 9.58,
        "return_vs_base_pct": 9.58,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": 1.62,
        "session_day": 7,
        "reference_price": 129.81,
        "reference_text": "$142.25 · +9.58% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-10-05T14:06:51.007319Z",
        "vwap_as_of": null
      },
      {
        "day": 6,
        "timestamp": "2026-10-03T11:27:18.905464Z",
        "date": "Session 6 · Oct 3, 2026 · 07:27 NYSE",
        "text": "P's tracked gain remained at 7.85% as shares rose 4.48% to $140.14, 0.53% above VWAP on near-average volume. Its 20-session lead over Technology edged to 35.34 points, but the preliminary fiscal outlook remains unverified by operating results, so the stronger session does not resolve whether guidance will translate into business performance.",
        "price": 140.14,
        "pct": 7.85,
        "return_vs_entry_pct": 7.96,
        "return_vs_base_pct": 7.96,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": 0.25,
        "session_day": 6,
        "reference_price": 129.81,
        "reference_text": "$140.14 · +7.96% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-10-02T21:58:36Z",
        "vwap_as_of": null
      },
      {
        "day": 6,
        "timestamp": "2026-10-02T20:26:14.648290Z",
        "date": "Session 6 · Oct 2, 2026 · 16:26 NYSE",
        "text": "P's tracked return rose 7.34 percentage points to +7.85% by session 6, and its 20-session lead over Technology reached 35.11 points. P stayed 0.53% above VWAP on 0.68 times average volume, but RSI at 92.58, a 3.32-ATR extension and no confirmed structure leave the move stretched. The near-even model and preliminary outlook, still without operating confirmation, keep continuation uncertain.",
        "price": 139.82,
        "pct": 7.85,
        "return_vs_entry_pct": 7.71,
        "return_vs_base_pct": 7.71,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": 6.96,
        "session_day": 6,
        "reference_price": 129.81,
        "reference_text": "$139.82 · +7.71% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": true,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "transcript-entry-5af379dff54a0dcd7cd0338fb3bf859eb1336bc3e047b9ca07871a94aa6dda45",
        "price_as_of": "2026-10-02T19:21:55.629539Z",
        "vwap_as_of": null
      },
      {
        "day": 4,
        "timestamp": "2026-09-30T22:01:20.589405Z",
        "date": "Session 4 · Sep 30, 2026 · 18:01 NYSE",
        "text": "P tracked gain fell 1.05 points to 0.51%. Shares were up 0.56% on the day at $130.78 but remained 0.38% below VWAP on 0.66 times average volume. Its 32.86-point 20-session lead over Technology remains substantial, while the quieter under-VWAP tape does not turn the preliminary FY2028 outlook into demonstrated operating results.",
        "price": 131.135,
        "pct": 0.51,
        "return_vs_entry_pct": 1.02,
        "return_vs_base_pct": 1.02,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": -0.77,
        "session_day": 4,
        "reference_price": 129.81,
        "reference_text": "$131.13 · +1.02% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-09-30T19:58:16.738162Z",
        "vwap_as_of": null
      },
      {
        "day": 4,
        "timestamp": "2026-09-30T22:01:20.589405Z",
        "date": "Session 4 · Sep 30, 2026 · 18:01 NYSE",
        "text": "P tracked gain fell 1.05 points to 0.51%. Shares were up 0.56% on the day at $130.78 but remained 0.38% below VWAP on 0.66 times average volume. Its 32.86-point 20-session lead over Technology remains substantial, while the quieter under-VWAP tape does not turn the preliminary FY2028 outlook into demonstrated operating results.",
        "price": 130.78,
        "pct": 0.51,
        "return_vs_entry_pct": 0.75,
        "return_vs_base_pct": 0.75,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": -0.27,
        "session_day": 4,
        "reference_price": 129.81,
        "reference_text": "$130.78 · +0.75% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-09-30T20:57:20Z",
        "vwap_as_of": null
      },
      {
        "day": 4,
        "timestamp": "2026-09-30T15:23:14.767624Z",
        "date": "Session 4 · Sep 30, 2026 · 11:23 NYSE",
        "text": "P's tracked return advanced 1.61 percentage points to a 1.56% gain. The 10 a.m. capture at 132.14 USD was 1.61% higher and 0.05% above VWAP, but volume was only 26% of its usual pace for this time. The 20-session lead over Technology narrowed to 33.92 points; shares remain near the yearly high and 2.90 ATR above the EMA reference, with no confirmed structure. The price response improved, while the September investor-day outlook still lacks direct confirmation in this packet and delivered results.",
        "price": 132.14,
        "pct": 1.56,
        "return_vs_entry_pct": 1.79,
        "return_vs_base_pct": 1.79,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": 1.61,
        "session_day": 4,
        "reference_price": 129.81,
        "reference_text": "$132.14 · +1.79% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-09-30T14:10:11.628897Z",
        "vwap_as_of": null
      },
      {
        "day": 3,
        "timestamp": "2026-09-29T21:53:24.058600Z",
        "date": "Session 3 · Sep 29, 2026 · 17:53 NYSE",
        "text": "P's tracked return fell 0.42 points to -0.05% as shares rose 0.50% to $130.05, essentially at session VWAP. Its 35.62-point 20-session lead over Technology remains strong, but dollar volume was 65% of normal, the price is near its yearly high and no structure is confirmed; the preliminary outlook remains unverified by delivered results.",
        "price": 130.05,
        "pct": -0.05,
        "return_vs_entry_pct": 0.18,
        "return_vs_base_pct": 0.18,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": -0.69,
        "session_day": 3,
        "reference_price": 129.81,
        "reference_text": "$130.05 · +0.18% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-09-29T21:14:25Z",
        "vwap_as_of": null
      },
      {
        "day": 3,
        "timestamp": "2026-09-29T19:55:50.084470Z",
        "date": "Session 3 · Sep 29, 2026 · 15:55 NYSE",
        "text": "P's tracked return recovered 0.92 percentage points to +0.37% as shares rose 1.19% to $130.95 and held 0.68% above the session volume-weighted average price. Its 36.55-point lead over Technology across 20 sessions remains strong, but dollar volume was 45% of its 20-day norm, price is near its yearly high and no structure is confirmed; the rebound supports the market test without verifying the preliminary outlook or showing operating conversion.",
        "price": 130.945,
        "pct": 0.37,
        "return_vs_entry_pct": 0.87,
        "return_vs_base_pct": 0.87,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": 1.19,
        "session_day": 3,
        "reference_price": 129.81,
        "reference_text": "$130.94 · +0.87% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-09-29T19:21:52.249581Z",
        "vwap_as_of": null
      },
      {
        "day": 2,
        "timestamp": "2026-09-28T22:01:13.448798Z",
        "date": "Session 2 · Sep 28, 2026 · 18:01 NYSE",
        "text": "P tracked return fell 0.90 points from +0.35% to -0.55%, even as shares rose 2.70% to $129.40 and closed 0.87% above the session volume-weighted average price. It remains 33.78 points ahead of Technology over 20 sessions, but price is 3.04 average daily ranges above its 21-day average, structure is unconfirmed, and the packet still lacks direct issuer material for the September outlook; the move has not validated preliminary guidance.",
        "price": 129.4,
        "pct": -0.55,
        "return_vs_entry_pct": -0.32,
        "return_vs_base_pct": -0.32,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": -0.96,
        "session_day": 2,
        "reference_price": 129.81,
        "reference_text": "$129.40 · -0.32% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-09-28T21:09:32Z",
        "vwap_as_of": null
      },
      {
        "day": 2,
        "timestamp": "2026-09-28T20:19:23.393501Z",
        "date": "Session 2 · Sep 28, 2026 · 16:19 NYSE",
        "text": "P's tracked return improved 2.65 percentage points to +0.35% while shares gained 3.68%, ending 1.84% above the session's volume-weighted average price near the high on 0.72 times average volume. It still leads Technology by 34.88 points over 20 sessions, but the rebound is extended and the model remains near even; the September investor-day outlook still lacks operating confirmation.",
        "price": 130.64,
        "pct": 0.35,
        "return_vs_entry_pct": 0.64,
        "return_vs_base_pct": 0.64,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": 3.07,
        "session_day": 2,
        "reference_price": 129.81,
        "reference_text": "$130.64 · +0.64% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": true,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "transcript-entry-225f247a512ac20cae4458aed9c4d6fc51ade028416f0bb94cc3d5659b3e0f33",
        "price_as_of": "2026-09-28T19:21:40.218900Z",
        "vwap_as_of": null
      },
      {
        "day": 2,
        "timestamp": "2026-09-28T15:31:04.420545Z",
        "date": "Session 2 · Sep 28, 2026 · 11:31 NYSE",
        "text": "P narrowed its tracked loss by 0.86 points to 2.30%, but price remained 0.65% below the $127.48 session VWAP on low volume. Its 20-session lead over Technology is still large, yet this package contains no new direct issuer disclosure confirming the cited full-year guidance and preliminary next-year outlook, so the event thesis remains unverified.",
        "price": 126.65,
        "pct": -2.3,
        "return_vs_entry_pct": -2.43,
        "return_vs_base_pct": -2.43,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": 0.51,
        "session_day": 2,
        "reference_price": 129.81,
        "reference_text": "$126.65 · -2.43% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-09-28T14:06:10.888804Z",
        "vwap_as_of": null
      },
      {
        "day": 1,
        "timestamp": "2026-09-25T22:49:43.547106Z",
        "date": "Session 1 · Sep 25, 2026 · 18:49 NYSE",
        "text": "P's tracked loss narrowed 1.66 percentage points to 3.16% on session 1. The $126.00 capture was 0.45% above VWAP on 1.42 times average volume, while the 20-session lead over Technology remains 22.90 points; no price structure was confirmed. This is an early repair from the initial decline, but one session and the reaffirmed outlook do not establish that the preliminary FY2028 forecast will be achieved.",
        "price": 126.0,
        "pct": -3.16,
        "return_vs_entry_pct": -2.94,
        "return_vs_base_pct": -2.94,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": 2.44,
        "session_day": 1,
        "reference_price": 129.81,
        "reference_text": "$126.00 · -2.94% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-09-25T21:04:22Z",
        "vwap_as_of": null
      },
      {
        "day": 1,
        "timestamp": "2026-09-25T15:03:44.699620Z",
        "date": "Session 1 · Sep 25, 2026 · 11:03 NYSE",
        "text": "P's tracked loss narrowed 1.51 percentage points to -4.82% as shares rose 0.77% to $122.82, yet the 10 a.m. price remained 1.48% below VWAP near the range low on 0.17 times average dollar volume. Its 20-session lead over Technology remains 20.16 points, and the reaffirmed outlook is still a testable premise, but today's weak position does not confirm that the forecast is driving durable repricing.",
        "price": 122.82,
        "pct": -4.82,
        "return_vs_entry_pct": -5.38,
        "return_vs_base_pct": -5.38,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": 0.73,
        "session_day": 1,
        "reference_price": 129.81,
        "reference_text": "$122.82 · -5.38% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-09-25T14:06:22.073520Z",
        "vwap_as_of": null
      },
      {
        "day": 0,
        "timestamp": "2026-09-24T21:32:58.131362Z",
        "date": "Session 0 · Sep 24, 2026 · 17:32 NYSE",
        "text": "Everpure's tracked loss widened 1.14 percentage points to 6.33% as shares jumped 11.15% to $121.88 on 2.77 times average volume, but the regular-session price remained 3.68% below VWAP and no structure is confirmed. A later post-market capture recovered to $123.88, up 1.64% from the close, while still below the session VWAP; the outlook-led thesis remains unconfirmed after the high-volume fade.",
        "price": 121.88,
        "pct": -6.33,
        "return_vs_entry_pct": -6.11,
        "return_vs_base_pct": -6.11,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": -1.47,
        "session_day": 0,
        "reference_price": 129.81,
        "reference_text": "$121.88 · -6.11% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": false,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "",
        "price_as_of": "2026-09-24T21:18:46Z",
        "vwap_as_of": null
      },
      {
        "day": 0,
        "timestamp": "2026-09-24T19:52:32.990302Z",
        "date": "Session 0 · Sep 24, 2026 · 15:52 NYSE",
        "text": "Everpure was up 12.9% from the prior close on 2.23 times its three-month average volume, but at the 2:21 p.m. ET snapshot it was 2.17% below VWAP and its tracked return remained -5.19% from the published start. The 20-session lead over Technology was still 13.29 points, yet the packet lacks direct issuer material for the September 23 outlook and shows no operating conversion, leaving the guidance thesis unconfirmed after a high-volume fade.",
        "price": 123.79,
        "pct": -5.19,
        "return_vs_entry_pct": -4.64,
        "return_vs_base_pct": -4.64,
        "return_vs_prior_pct": null,
        "previous_regular_close": null,
        "change_vs_prior_session_pct": -4.64,
        "session_day": 0,
        "reference_price": 129.81,
        "reference_text": "$123.79 · -4.64% from $129.81 base",
        "timing": "",
        "market_marker": null,
        "extended_hours": null,
        "relevant": true,
        "active_relevant": false,
        "terminal_closure": false,
        "transcript_anchor": "transcript-entry-8a1873399a9c013496790bc042a48a70a90e3aaecbe2fa7a61c072d8471e95eb",
        "price_as_of": "2026-09-24T19:21:16.869314Z",
        "vwap_as_of": null
      }
    ],
    "observed_outcomes": [
      {
        "label": "+1 sessions",
        "status": "complete",
        "return": -3.16,
        "reference_text": "-3.16% from $129.81 base",
        "price": 126.0,
        "updated": "Sep 25, 2026 · 17:05 NYSE",
        "mfe": -1.35,
        "mae": -6.0
      },
      {
        "label": "+5 sessions",
        "status": "complete",
        "return": 3.09,
        "reference_text": "+3.09% from $129.81 base",
        "price": 134.13,
        "updated": "Oct 2, 2026 · 15:37 NYSE",
        "mfe": 4.28,
        "mae": -6.0
      },
      {
        "label": "+10 sessions",
        "status": "complete",
        "return": 15.73,
        "reference_text": "+15.73% from $129.81 base",
        "price": 150.57,
        "updated": "Oct 8, 2026 · 17:43 NYSE",
        "mfe": 20.71,
        "mae": -6.0
      },
      {
        "label": "+15 sessions",
        "status": "complete",
        "return": 2.53,
        "reference_text": "+2.53% from $129.81 base",
        "price": 133.4,
        "updated": "Oct 15, 2026 · 17:05 NYSE",
        "mfe": 21.11,
        "mae": -6.0
      }
    ],
    "candidate_comparison_history": [
      {
        "day": 0,
        "timestamp": "2026-09-24T19:52:32.990302Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-09-24T19:52:32.990302Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 123.79,
              "base_price": 129.805,
              "return_since_base_pct": -4.6339,
              "session_return_pct": 12.9,
              "change_since_prior_pct": 0.3404,
              "volume_ratio": 2.23,
              "rsi": 75.18,
              "vwap": 126.54,
              "vwap_distance_pct": -2.1732,
              "position_52w_pct": 94.2,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T19:21:16.869314Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "107.85 > 102.99 > 96.05",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-09-24T19:21:16.869314Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 126.18,
              "base_price": 117.79,
              "return_since_base_pct": 7.1228,
              "session_return_pct": 16.2735,
              "change_since_prior_pct": -0.1635,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 10.5872,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T19:50:10Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T19:50:10Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1190.34,
              "base_price": 1186.34,
              "return_since_base_pct": 0.3372,
              "session_return_pct": 3.4188,
              "change_since_prior_pct": 0.0618,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T19:50:17Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T19:50:17Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.29,
              "base_price": 1.2403,
              "return_since_base_pct": 4.0071,
              "session_return_pct": 18.1818,
              "change_since_prior_pct": -2.6415,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 0.7812,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T19:50:23Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T19:50:23Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.495,
              "base_price": 1.655,
              "return_since_base_pct": -9.6677,
              "session_return_pct": 1.7007,
              "change_since_prior_pct": -0.6645,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -6.5625,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T19:50:06Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T19:50:06Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.26,
              "base_price": 10.1595,
              "return_since_base_pct": 0.9892,
              "session_return_pct": 10.5603,
              "change_since_prior_pct": -0.5814,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 2.4975,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T19:50:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T19:50:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 0,
        "timestamp": "2026-09-24T21:32:58.131362Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-09-24T21:32:58.131362Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 123.88,
              "base_price": 129.805,
              "return_since_base_pct": -4.5645,
              "session_return_pct": 11.15,
              "change_since_prior_pct": 0.0727,
              "volume_ratio": 2.77,
              "rsi": 74.4,
              "vwap": 126.54,
              "vwap_distance_pct": -2.1021,
              "position_52w_pct": 92.8,
              "extended_hours_pct": 1.64,
              "as_of": "2026-09-24T21:18:46Z",
              "source": "sealed_extended_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "107.47 > 102.82 > 95.98",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-09-24T21:18:46Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": -0.7529,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": -0.7099,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.6434,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": -1.01,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": -0.6823,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 1,
        "timestamp": "2026-09-25T15:03:44.699620Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-09-25T15:03:44.699620Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 122.82,
              "base_price": 129.805,
              "return_since_base_pct": -5.3811,
              "session_return_pct": 0.77,
              "change_since_prior_pct": -0.8557,
              "volume_ratio": 0.24,
              "rsi": 71.5,
              "vwap": 124.67,
              "vwap_distance_pct": -1.4839,
              "position_52w_pct": 93.5,
              "extended_hours_pct": null,
              "as_of": "2026-09-25T14:06:22.073520Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "111.41 > 105.38 > 97.61",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-09-25T14:06:22.073520Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 1,
        "timestamp": "2026-09-25T22:49:43.547106Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-09-25T22:49:43.547106Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 126.81,
              "base_price": 129.805,
              "return_since_base_pct": -2.3073,
              "session_return_pct": 3.38,
              "change_since_prior_pct": 3.2487,
              "volume_ratio": 1.42,
              "rsi": 73.08,
              "vwap": 125.44,
              "vwap_distance_pct": 1.0922,
              "position_52w_pct": 95.9,
              "extended_hours_pct": 0.64,
              "as_of": "2026-09-25T21:04:22Z",
              "source": "sealed_extended_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "112.04 > 105.66 > 97.73",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-09-25T21:04:22Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 2,
        "timestamp": "2026-09-28T15:31:04.420545Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-09-28T15:31:04.420545Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 126.65,
              "base_price": 129.805,
              "return_since_base_pct": -2.4306,
              "session_return_pct": 0.52,
              "change_since_prior_pct": -0.1262,
              "volume_ratio": 0.18,
              "rsi": 72.61,
              "vwap": 127.48,
              "vwap_distance_pct": -0.6511,
              "position_52w_pct": 96.4,
              "extended_hours_pct": null,
              "as_of": "2026-09-28T14:06:10.888804Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "114.96 > 107.57 > 98.87",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-09-28T14:06:10.888804Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 2,
        "timestamp": "2026-09-28T20:19:23.393501Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-09-28T20:19:23.393501Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 130.64,
              "base_price": 129.805,
              "return_since_base_pct": 0.6433,
              "session_return_pct": 3.68,
              "change_since_prior_pct": 3.1504,
              "volume_ratio": 0.72,
              "rsi": 74.42,
              "vwap": 128.28,
              "vwap_distance_pct": 1.8397,
              "position_52w_pct": 99.4,
              "extended_hours_pct": null,
              "as_of": "2026-09-28T19:21:40.218900Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "115.76 > 107.93 > 99.02",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-09-28T19:21:40.218900Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 2,
        "timestamp": "2026-09-28T22:01:13.448798Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-09-28T22:01:13.448798Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 129.3,
              "base_price": 129.805,
              "return_since_base_pct": -0.389,
              "session_return_pct": 2.7,
              "change_since_prior_pct": -1.0257,
              "volume_ratio": 1.06,
              "rsi": 73.88,
              "vwap": 128.28,
              "vwap_distance_pct": 0.7951,
              "position_52w_pct": 98.5,
              "extended_hours_pct": -0.08,
              "as_of": "2026-09-28T21:09:32Z",
              "source": "sealed_extended_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "115.51 > 107.82 > 98.97",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-09-28T21:09:32Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 3,
        "timestamp": "2026-09-29T19:55:50.084470Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-09-29T19:55:50.084470Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 130.945,
              "base_price": 129.805,
              "return_since_base_pct": 0.8782,
              "session_return_pct": 1.19,
              "change_since_prior_pct": 1.2722,
              "volume_ratio": 0.63,
              "rsi": 79.92,
              "vwap": 130.06,
              "vwap_distance_pct": 0.6805,
              "position_52w_pct": 98.9,
              "extended_hours_pct": null,
              "as_of": "2026-09-29T19:21:52.249581Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "118.6 > 109.92 > 100.23",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-09-29T19:21:52.249581Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 3,
        "timestamp": "2026-09-29T21:53:24.058600Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-09-29T21:53:24.058600Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 130.05,
              "base_price": 129.805,
              "return_since_base_pct": 0.1887,
              "session_return_pct": 0.5,
              "change_since_prior_pct": -0.6835,
              "volume_ratio": 0.91,
              "rsi": 79.6,
              "vwap": 130.06,
              "vwap_distance_pct": -0.0077,
              "position_52w_pct": 98.2,
              "extended_hours_pct": 0.0,
              "as_of": "2026-09-29T21:14:25Z",
              "source": "sealed_extended_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "118.42 > 109.84 > 100.19",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-09-29T21:14:25Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 4,
        "timestamp": "2026-09-30T15:23:14.767624Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-09-30T15:23:14.767624Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 132.14,
              "base_price": 129.805,
              "return_since_base_pct": 1.7989,
              "session_return_pct": 1.61,
              "change_since_prior_pct": 1.6071,
              "volume_ratio": 0.08,
              "rsi": 84.67,
              "vwap": 132.08,
              "vwap_distance_pct": 0.0454,
              "position_52w_pct": 99.1,
              "extended_hours_pct": null,
              "as_of": "2026-09-30T14:10:11.628897Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "121.16 > 111.87 > 101.45",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "benchmark_excess_pct": {
                "sp500": 1.0075,
                "nasdaq100": 0.7974,
                "russell2000": 1.3866
              },
              "price_as_of": "2026-09-30T14:10:11.628897Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "benchmark_excess_pct": {
                "sp500": -0.5865,
                "nasdaq100": -0.7966,
                "russell2000": -0.2074
              },
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "benchmark_excess_pct": {
                "sp500": -0.7333,
                "nasdaq100": -0.9434,
                "russell2000": -0.3542
              },
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "benchmark_excess_pct": {
                "sp500": 0.071,
                "nasdaq100": -0.1391,
                "russell2000": 0.4501
              },
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "benchmark_excess_pct": {
                "sp500": 8.8775,
                "nasdaq100": 8.6674,
                "russell2000": 9.2566
              },
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [
            {
              "id": "sp500",
              "symbol": "^GSPC",
              "label": "S&P 500",
              "role": "benchmark",
              "price": 7717.06,
              "base_price": 7670.84,
              "return_since_base_pct": 0.6025,
              "session_return_pct": 0.6025,
              "as_of": "2026-09-30T14:59:02.277945Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            },
            {
              "id": "nasdaq100",
              "symbol": "^NDX",
              "label": "Nasdaq 100",
              "role": "benchmark",
              "price": 30585.883,
              "base_price": 30339.332,
              "return_since_base_pct": 0.8126,
              "session_return_pct": 0.8126,
              "as_of": "2026-09-30T14:59:02.277945Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            },
            {
              "id": "russell2000",
              "symbol": "^RUT",
              "label": "Russell 2000",
              "role": "benchmark",
              "price": 2814.1946,
              "base_price": 2807.922,
              "return_since_base_pct": 0.2234,
              "session_return_pct": 0.2234,
              "as_of": "2026-09-30T14:59:02.277945Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            }
          ],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 3
          }
        }
      },
      {
        "day": 4,
        "timestamp": "2026-09-30T22:01:20.589405Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-09-30T22:01:20.589405Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 130.88,
              "base_price": 129.805,
              "return_since_base_pct": 0.8282,
              "session_return_pct": 0.56,
              "change_since_prior_pct": -0.9535,
              "volume_ratio": 0.66,
              "rsi": 84.28,
              "vwap": 131.28,
              "vwap_distance_pct": -0.3047,
              "position_52w_pct": 98.1,
              "extended_hours_pct": 0.08,
              "as_of": "2026-09-30T20:57:20Z",
              "source": "sealed_extended_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "120.89 > 111.75 > 101.39",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "benchmark_excess_pct": {
                "sp500": -0.0425,
                "nasdaq100": -0.2526,
                "russell2000": 0.3366
              },
              "price_as_of": "2026-09-30T20:57:20Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "benchmark_excess_pct": {
                "sp500": -0.5865,
                "nasdaq100": -0.7966,
                "russell2000": -0.2074
              },
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "benchmark_excess_pct": {
                "sp500": -0.7333,
                "nasdaq100": -0.9434,
                "russell2000": -0.3542
              },
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "benchmark_excess_pct": {
                "sp500": 0.071,
                "nasdaq100": -0.1391,
                "russell2000": 0.4501
              },
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "benchmark_excess_pct": {
                "sp500": 8.8775,
                "nasdaq100": 8.6674,
                "russell2000": 9.2566
              },
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [
            {
              "id": "sp500",
              "symbol": "^GSPC",
              "label": "S&P 500",
              "role": "benchmark",
              "price": 7717.06,
              "base_price": 7670.84,
              "return_since_base_pct": 0.6025,
              "session_return_pct": 0.6025,
              "as_of": "2026-09-30T14:59:02.277945Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            },
            {
              "id": "nasdaq100",
              "symbol": "^NDX",
              "label": "Nasdaq 100",
              "role": "benchmark",
              "price": 30585.883,
              "base_price": 30339.332,
              "return_since_base_pct": 0.8126,
              "session_return_pct": 0.8126,
              "as_of": "2026-09-30T14:59:02.277945Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            },
            {
              "id": "russell2000",
              "symbol": "^RUT",
              "label": "Russell 2000",
              "role": "benchmark",
              "price": 2814.1946,
              "base_price": 2807.922,
              "return_since_base_pct": 0.2234,
              "session_return_pct": 0.2234,
              "as_of": "2026-09-30T14:59:02.277945Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            }
          ],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 3
          }
        }
      },
      {
        "day": 4,
        "timestamp": "2026-09-30T22:01:20.589405Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-09-30T22:01:20.589405Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 131.135,
              "base_price": 129.805,
              "return_since_base_pct": 1.0246,
              "session_return_pct": 0.83,
              "change_since_prior_pct": 0.1948,
              "volume_ratio": 0.48,
              "rsi": 84.39,
              "vwap": 131.28,
              "vwap_distance_pct": -0.1105,
              "position_52w_pct": 98.4,
              "extended_hours_pct": null,
              "as_of": "2026-09-30T19:58:16.738162Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "120.97 > 111.78 > 101.41",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-09-30T19:58:16.738162Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 6,
        "timestamp": "2026-10-02T20:26:14.648290Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-02T20:26:14.648290Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 139.82,
              "base_price": 129.805,
              "return_since_base_pct": 7.7154,
              "session_return_pct": 4.24,
              "change_since_prior_pct": 6.6229,
              "volume_ratio": 0.68,
              "rsi": 92.58,
              "vwap": 139.09,
              "vwap_distance_pct": 0.5248,
              "position_52w_pct": 99.5,
              "extended_hours_pct": null,
              "as_of": "2026-10-02T19:21:55.629539Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "126.8 > 116.15 > 104.13",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "benchmark_excess_pct": {
                "sp500": 3.5067,
                "nasdaq100": 3.2951,
                "russell2000": 3.2573
              },
              "price_as_of": "2026-10-02T19:21:55.629539Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "benchmark_excess_pct": {
                "sp500": -0.7173,
                "nasdaq100": -0.9289,
                "russell2000": -0.9667
              },
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "benchmark_excess_pct": {
                "sp500": -0.8641,
                "nasdaq100": -1.0757,
                "russell2000": -1.1135
              },
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "benchmark_excess_pct": {
                "sp500": -0.0598,
                "nasdaq100": -0.2714,
                "russell2000": -0.3092
              },
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "benchmark_excess_pct": {
                "sp500": 8.7467,
                "nasdaq100": 8.5351,
                "russell2000": 8.4973
              },
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [
            {
              "id": "sp500",
              "symbol": "^GSPC",
              "label": "S&P 500",
              "role": "benchmark",
              "price": 7722.67,
              "base_price": 7666.45,
              "return_since_base_pct": 0.7333,
              "session_return_pct": 0.7333,
              "as_of": "2026-10-02T19:56:33.562446Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            },
            {
              "id": "nasdaq100",
              "symbol": "^NDX",
              "label": "Nasdaq 100",
              "role": "benchmark",
              "price": 30789.762,
              "base_price": 30501.56,
              "return_since_base_pct": 0.9449,
              "session_return_pct": 0.9449,
              "as_of": "2026-10-02T19:56:33.562446Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            },
            {
              "id": "russell2000",
              "symbol": "^RUT",
              "label": "Russell 2000",
              "role": "benchmark",
              "price": 2834.2056,
              "base_price": 2806.625,
              "return_since_base_pct": 0.9827,
              "session_return_pct": 0.9827,
              "as_of": "2026-10-02T19:56:33.562446Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            }
          ],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 3
          }
        }
      },
      {
        "day": 6,
        "timestamp": "2026-10-03T11:27:18.905464Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-03T11:27:18.905464Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 140.78,
              "base_price": 129.805,
              "return_since_base_pct": 8.455,
              "session_return_pct": 4.48,
              "change_since_prior_pct": 0.6866,
              "volume_ratio": 1.1,
              "rsi": 92.63,
              "vwap": 139.09,
              "vwap_distance_pct": 1.215,
              "position_52w_pct": 99.5,
              "extended_hours_pct": 0.46,
              "as_of": "2026-10-02T21:58:36Z",
              "source": "sealed_extended_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "126.86 > 116.18 > 104.15",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-10-02T21:58:36Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 7,
        "timestamp": "2026-10-05T15:27:23.895944Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-05T15:27:23.895944Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 142.25,
              "base_price": 129.805,
              "return_since_base_pct": 9.5875,
              "session_return_pct": 1.51,
              "change_since_prior_pct": 1.0442,
              "volume_ratio": 0.19,
              "rsi": 92.48,
              "vwap": 142.51,
              "vwap_distance_pct": -0.1824,
              "position_52w_pct": 99.1,
              "extended_hours_pct": null,
              "as_of": "2026-10-05T14:06:51.007319Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "129.94 > 118.55 > 105.64",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "benchmark_excess_pct": {
                "sp500": 1.1175,
                "nasdaq100": 1.0042,
                "russell2000": 1.3098
              },
              "price_as_of": "2026-10-05T14:06:51.007319Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "benchmark_excess_pct": {
                "sp500": -0.3765,
                "nasdaq100": -0.4898,
                "russell2000": -0.1842
              },
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "benchmark_excess_pct": {
                "sp500": -0.5233,
                "nasdaq100": -0.6366,
                "russell2000": -0.331
              },
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "benchmark_excess_pct": {
                "sp500": 0.281,
                "nasdaq100": 0.1677,
                "russell2000": 0.4733
              },
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "benchmark_excess_pct": {
                "sp500": 9.0875,
                "nasdaq100": 8.9742,
                "russell2000": 9.2798
              },
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [
            {
              "id": "sp500",
              "symbol": "^GSPC",
              "label": "S&P 500",
              "role": "benchmark",
              "price": 7753.03,
              "base_price": 7722.72,
              "return_since_base_pct": 0.3925,
              "session_return_pct": 0.3925,
              "as_of": "2026-10-05T15:13:52.600430Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            },
            {
              "id": "nasdaq100",
              "symbol": "^NDX",
              "label": "Nasdaq 100",
              "role": "benchmark",
              "price": 30963.771,
              "base_price": 30807.932,
              "return_since_base_pct": 0.5058,
              "session_return_pct": 0.5058,
              "as_of": "2026-10-05T15:13:52.600430Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            },
            {
              "id": "russell2000",
              "symbol": "^RUT",
              "label": "Russell 2000",
              "role": "benchmark",
              "price": 2838.5664,
              "base_price": 2832.8948,
              "return_since_base_pct": 0.2002,
              "session_return_pct": 0.2002,
              "as_of": "2026-10-05T15:13:52.600430Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            }
          ],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 3
          }
        }
      },
      {
        "day": 7,
        "timestamp": "2026-10-05T20:27:50.515848Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-05T20:27:50.515848Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 143.08,
              "base_price": 129.805,
              "return_since_base_pct": 10.2269,
              "session_return_pct": 2.1,
              "change_since_prior_pct": 0.5835,
              "volume_ratio": 0.65,
              "rsi": 92.59,
              "vwap": 142.09,
              "vwap_distance_pct": 0.6967,
              "position_52w_pct": 99.7,
              "extended_hours_pct": null,
              "as_of": "2026-10-05T19:21:38.104627Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "130.1 > 118.62 > 105.67",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-10-05T19:21:38.104627Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 7,
        "timestamp": "2026-10-05T22:32:32.546138Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-05T22:32:32.546138Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 144.69,
              "base_price": 129.805,
              "return_since_base_pct": 11.4672,
              "session_return_pct": 2.67,
              "change_since_prior_pct": 1.1252,
              "volume_ratio": 1.11,
              "rsi": 92.7,
              "vwap": 142.09,
              "vwap_distance_pct": 1.8298,
              "position_52w_pct": 99.9,
              "extended_hours_pct": 0.56,
              "as_of": "2026-10-05T21:01:37Z",
              "source": "sealed_extended_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "130.26 > 118.7 > 105.7",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "benchmark_excess_pct": {
                "sp500": 2.0066,
                "nasdaq100": 1.7984,
                "russell2000": 2.1673
              },
              "price_as_of": "2026-10-05T21:01:37Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "benchmark_excess_pct": {
                "sp500": -0.6474,
                "nasdaq100": -0.8556,
                "russell2000": -0.4867
              },
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "benchmark_excess_pct": {
                "sp500": -0.7942,
                "nasdaq100": -1.0024,
                "russell2000": -0.6335
              },
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "benchmark_excess_pct": {
                "sp500": 0.0101,
                "nasdaq100": -0.1981,
                "russell2000": 0.1708
              },
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "benchmark_excess_pct": {
                "sp500": 8.8166,
                "nasdaq100": 8.6084,
                "russell2000": 8.9773
              },
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [
            {
              "id": "sp500",
              "symbol": "^GSPC",
              "label": "S&P 500",
              "role": "benchmark",
              "price": 7773.95,
              "base_price": 7722.72,
              "return_since_base_pct": 0.6634,
              "session_return_pct": 0.6634,
              "as_of": "2026-10-05T22:30:02.530881Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            },
            {
              "id": "nasdaq100",
              "symbol": "^NDX",
              "label": "Nasdaq 100",
              "role": "benchmark",
              "price": 31076.441,
              "base_price": 30807.932,
              "return_since_base_pct": 0.8716,
              "session_return_pct": 0.8716,
              "as_of": "2026-10-05T22:30:02.530881Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            },
            {
              "id": "russell2000",
              "symbol": "^RUT",
              "label": "Russell 2000",
              "role": "benchmark",
              "price": 2847.1357,
              "base_price": 2832.8948,
              "return_since_base_pct": 0.5027,
              "session_return_pct": 0.5027,
              "as_of": "2026-10-05T22:30:02.530881Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            }
          ],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 3
          }
        }
      },
      {
        "day": 8,
        "timestamp": "2026-10-06T14:48:21.791189Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-06T14:48:21.791189Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 145.165,
              "base_price": 129.805,
              "return_since_base_pct": 11.8331,
              "session_return_pct": 0.89,
              "change_since_prior_pct": 0.3283,
              "volume_ratio": 0.15,
              "rsi": 92.78,
              "vwap": 146.94,
              "vwap_distance_pct": -1.208,
              "position_52w_pct": 97.6,
              "extended_hours_pct": null,
              "as_of": "2026-10-06T14:06:59.842254Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "133.24 > 121.1 > 107.25",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-10-06T14:06:59.842254Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 8,
        "timestamp": "2026-10-06T20:03:31.562930Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-06T20:03:31.562930Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 148.96,
              "base_price": 129.805,
              "return_since_base_pct": 14.7568,
              "session_return_pct": 3.53,
              "change_since_prior_pct": 2.6143,
              "volume_ratio": 0.5,
              "rsi": 93.25,
              "vwap": 147.24,
              "vwap_distance_pct": 1.1682,
              "position_52w_pct": 100.0,
              "extended_hours_pct": null,
              "as_of": "2026-10-06T19:21:35.651397Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "134.0 > 121.45 > 107.4",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "benchmark_excess_pct": {
                "sp500": 2.9356,
                "nasdaq100": 3.0429,
                "russell2000": 4.2443
              },
              "price_as_of": "2026-10-06T19:21:35.651397Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "benchmark_excess_pct": {
                "sp500": -0.5784,
                "nasdaq100": -0.4711,
                "russell2000": 0.7303
              },
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "benchmark_excess_pct": {
                "sp500": -0.7252,
                "nasdaq100": -0.6179,
                "russell2000": 0.5835
              },
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "benchmark_excess_pct": {
                "sp500": 0.0791,
                "nasdaq100": 0.1864,
                "russell2000": 1.3878
              },
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "benchmark_excess_pct": {
                "sp500": 8.8856,
                "nasdaq100": 8.9929,
                "russell2000": 10.1943
              },
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [
            {
              "id": "sp500",
              "symbol": "^GSPC",
              "label": "S&P 500",
              "role": "benchmark",
              "price": 7820.16,
              "base_price": 7773.95,
              "return_since_base_pct": 0.5944,
              "session_return_pct": 0.5944,
              "as_of": "2026-10-06T19:59:33.026072Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            },
            {
              "id": "nasdaq100",
              "symbol": "^NDX",
              "label": "Nasdaq 100",
              "role": "benchmark",
              "price": 31227.828,
              "base_price": 31076.441,
              "return_since_base_pct": 0.4871,
              "session_return_pct": 0.4871,
              "as_of": "2026-10-06T19:59:33.026072Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            },
            {
              "id": "russell2000",
              "symbol": "^RUT",
              "label": "Russell 2000",
              "role": "benchmark",
              "price": 2826.798,
              "base_price": 2847.1357,
              "return_since_base_pct": -0.7143,
              "session_return_pct": -0.7143,
              "as_of": "2026-10-06T19:59:33.026072Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            }
          ],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 3
          }
        }
      },
      {
        "day": 9,
        "timestamp": "2026-10-07T15:08:19.734999Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-07T15:08:19.734999Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 148.345,
              "base_price": 129.805,
              "return_since_base_pct": 14.283,
              "session_return_pct": 0.78,
              "change_since_prior_pct": -0.4129,
              "volume_ratio": 0.11,
              "rsi": 92.34,
              "vwap": 147.76,
              "vwap_distance_pct": 0.3959,
              "position_52w_pct": 99.1,
              "extended_hours_pct": null,
              "as_of": "2026-10-07T14:06:33.450164Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "136.59 > 123.75 > 108.94",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-10-07T14:06:33.450164Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 9,
        "timestamp": "2026-10-07T19:57:46.256019Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-07T19:57:46.256019Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 152.26,
              "base_price": 129.805,
              "return_since_base_pct": 17.299,
              "session_return_pct": 3.44,
              "change_since_prior_pct": 2.6391,
              "volume_ratio": 0.74,
              "rsi": 92.88,
              "vwap": 150.23,
              "vwap_distance_pct": 1.3513,
              "position_52w_pct": 99.7,
              "extended_hours_pct": null,
              "as_of": "2026-10-07T19:21:41.146640Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "137.37 > 124.1 > 109.09",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-10-07T19:21:41.146640Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 9,
        "timestamp": "2026-10-07T22:09:21.669815Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-07T22:09:21.669815Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 152.66,
              "base_price": 129.805,
              "return_since_base_pct": 17.6072,
              "session_return_pct": 3.71,
              "change_since_prior_pct": 0.2627,
              "volume_ratio": 1.11,
              "rsi": 92.93,
              "vwap": 150.23,
              "vwap_distance_pct": 1.6175,
              "position_52w_pct": 99.5,
              "extended_hours_pct": 0.0,
              "as_of": "2026-10-07T21:26:32Z",
              "source": "sealed_extended_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "137.45 > 124.14 > 109.11",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "benchmark_excess_pct": {
                "sp500": 3.9295,
                "nasdaq100": 3.9169,
                "russell2000": 5.0206
              },
              "price_as_of": "2026-10-07T21:26:32Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "benchmark_excess_pct": {
                "sp500": 0.2355,
                "nasdaq100": 0.2229,
                "russell2000": 1.3266
              },
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "benchmark_excess_pct": {
                "sp500": 0.0887,
                "nasdaq100": 0.0761,
                "russell2000": 1.1798
              },
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "benchmark_excess_pct": {
                "sp500": 0.893,
                "nasdaq100": 0.8804,
                "russell2000": 1.9841
              },
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "benchmark_excess_pct": {
                "sp500": 9.6995,
                "nasdaq100": 9.6869,
                "russell2000": 10.7906
              },
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [
            {
              "id": "sp500",
              "symbol": "^GSPC",
              "label": "S&P 500",
              "role": "benchmark",
              "price": 7801.77,
              "base_price": 7818.93,
              "return_since_base_pct": -0.2195,
              "session_return_pct": -0.2195,
              "as_of": "2026-10-07T22:09:00.135906Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            },
            {
              "id": "nasdaq100",
              "symbol": "^NDX",
              "label": "Nasdaq 100",
              "role": "benchmark",
              "price": 31160.076,
              "base_price": 31224.686,
              "return_since_base_pct": -0.2069,
              "session_return_pct": -0.2069,
              "as_of": "2026-10-07T22:09:00.135906Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            },
            {
              "id": "russell2000",
              "symbol": "^RUT",
              "label": "Russell 2000",
              "role": "benchmark",
              "price": 2793.204,
              "base_price": 2830.2974,
              "return_since_base_pct": -1.3106,
              "session_return_pct": -1.3106,
              "as_of": "2026-10-07T22:09:00.135906Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            }
          ],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 3
          }
        }
      },
      {
        "day": 10,
        "timestamp": "2026-10-08T15:02:05.826724Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-08T15:02:05.826724Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 154.385,
              "base_price": 129.805,
              "return_since_base_pct": 18.9361,
              "session_return_pct": 1.13,
              "change_since_prior_pct": 1.13,
              "volume_ratio": 0.19,
              "rsi": 93.12,
              "vwap": 153.47,
              "vwap_distance_pct": 0.5962,
              "position_52w_pct": 99.6,
              "extended_hours_pct": null,
              "as_of": "2026-10-08T14:06:42.195821Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "140.84 > 126.89 > 110.88",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "benchmark_excess_pct": {
                "sp500": 1.4324,
                "nasdaq100": 1.5963,
                "russell2000": 1.7102
              },
              "price_as_of": "2026-10-08T14:06:42.195821Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "benchmark_excess_pct": {
                "sp500": 0.3184,
                "nasdaq100": 0.4823,
                "russell2000": 0.5962
              },
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "benchmark_excess_pct": {
                "sp500": 0.1716,
                "nasdaq100": 0.3355,
                "russell2000": 0.4494
              },
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "benchmark_excess_pct": {
                "sp500": 0.9759,
                "nasdaq100": 1.1398,
                "russell2000": 1.2537
              },
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "benchmark_excess_pct": {
                "sp500": 9.7824,
                "nasdaq100": 9.9463,
                "russell2000": 10.0602
              },
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [
            {
              "id": "sp500",
              "symbol": "^GSPC",
              "label": "S&P 500",
              "role": "benchmark",
              "price": 7778.18,
              "base_price": 7801.77,
              "return_since_base_pct": -0.3024,
              "session_return_pct": -0.3024,
              "as_of": "2026-10-08T14:55:12.664497Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            },
            {
              "id": "nasdaq100",
              "symbol": "^NDX",
              "label": "Nasdaq 100",
              "role": "benchmark",
              "price": 31014.77,
              "base_price": 31160.076,
              "return_since_base_pct": -0.4663,
              "session_return_pct": -0.4663,
              "as_of": "2026-10-08T14:55:12.664497Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            },
            {
              "id": "russell2000",
              "symbol": "^RUT",
              "label": "Russell 2000",
              "role": "benchmark",
              "price": 2776.999,
              "base_price": 2793.204,
              "return_since_base_pct": -0.5802,
              "session_return_pct": -0.5802,
              "as_of": "2026-10-08T14:55:12.664497Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            }
          ],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 3
          }
        }
      },
      {
        "day": 10,
        "timestamp": "2026-10-08T20:15:38.661260Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-08T20:15:38.661260Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 151.375,
              "base_price": 129.805,
              "return_since_base_pct": 16.6172,
              "session_return_pct": -0.84,
              "change_since_prior_pct": -1.9497,
              "volume_ratio": 0.9,
              "rsi": 90.84,
              "vwap": 153.75,
              "vwap_distance_pct": -1.5447,
              "position_52w_pct": 96.4,
              "extended_hours_pct": null,
              "as_of": "2026-10-08T19:22:13.087729Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "140.24 > 126.62 > 110.77",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-10-08T19:22:13.087729Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 10,
        "timestamp": "2026-10-08T21:54:01.207428Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-08T21:54:01.207428Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 150.66,
              "base_price": 129.805,
              "return_since_base_pct": 16.0664,
              "session_return_pct": -1.37,
              "change_since_prior_pct": -0.4723,
              "volume_ratio": 1.26,
              "rsi": 89.6,
              "vwap": 153.75,
              "vwap_distance_pct": -2.0098,
              "position_52w_pct": 95.9,
              "extended_hours_pct": 0.06,
              "as_of": "2026-10-08T21:33:36Z",
              "source": "sealed_extended_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "140.08 > 126.54 > 110.74",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-10-08T21:33:36Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 11,
        "timestamp": "2026-10-09T14:49:10.534184Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-09T14:49:10.534184Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 151.675,
              "base_price": 129.805,
              "return_since_base_pct": 16.8483,
              "session_return_pct": 0.73,
              "change_since_prior_pct": 0.6737,
              "volume_ratio": 0.12,
              "rsi": 87.85,
              "vwap": 152.23,
              "vwap_distance_pct": -0.3646,
              "position_52w_pct": 96.6,
              "extended_hours_pct": null,
              "as_of": "2026-10-09T14:06:45.252947Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "142.4 > 128.83 > 112.34",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-10-09T14:06:45.252947Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 11,
        "timestamp": "2026-10-09T19:39:37.774560Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-09T19:39:37.774560Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 154.525,
              "base_price": 129.805,
              "return_since_base_pct": 19.044,
              "session_return_pct": 2.63,
              "change_since_prior_pct": 1.879,
              "volume_ratio": 0.56,
              "rsi": 88.5,
              "vwap": 152.42,
              "vwap_distance_pct": 1.3811,
              "position_52w_pct": 98.4,
              "extended_hours_pct": null,
              "as_of": "2026-10-09T19:21:12.332945Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "142.97 > 129.09 > 112.45",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-10-09T19:21:12.332945Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 12,
        "timestamp": "2026-10-12T19:43:22.835396Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-12T19:43:22.835396Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 154.37,
              "base_price": 129.805,
              "return_since_base_pct": 18.9245,
              "session_return_pct": -0.08,
              "change_since_prior_pct": -0.1003,
              "volume_ratio": 0.49,
              "rsi": 93.15,
              "vwap": 153.5,
              "vwap_distance_pct": 0.5668,
              "position_52w_pct": 98.3,
              "extended_hours_pct": null,
              "as_of": "2026-10-12T19:23:05.083706Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "145.24 > 131.38 > 114.1",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-10-12T19:23:05.083706Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 12,
        "timestamp": "2026-10-12T20:15:21.927330Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-12T20:15:21.927330Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 154.32,
              "base_price": 129.805,
              "return_since_base_pct": 18.886,
              "session_return_pct": -0.11,
              "change_since_prior_pct": -0.0324,
              "volume_ratio": 0.46,
              "rsi": 93.06,
              "vwap": 153.46,
              "vwap_distance_pct": 0.5604,
              "position_52w_pct": 98.3,
              "extended_hours_pct": null,
              "as_of": "2026-10-12T18:48:37.209746Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "145.23 > 131.38 > 114.09",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "benchmark_excess_pct": {
                "sp500": -0.055,
                "nasdaq100": 0.5973,
                "russell2000": 0.3098
              },
              "price_as_of": "2026-10-12T18:48:37.209746Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "benchmark_excess_pct": {
                "sp500": 0.071,
                "nasdaq100": 0.7233,
                "russell2000": 0.4358
              },
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "benchmark_excess_pct": {
                "sp500": -0.0758,
                "nasdaq100": 0.5765,
                "russell2000": 0.289
              },
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "benchmark_excess_pct": {
                "sp500": 0.7285,
                "nasdaq100": 1.3808,
                "russell2000": 1.0933
              },
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "benchmark_excess_pct": {
                "sp500": 9.535,
                "nasdaq100": 10.1873,
                "russell2000": 9.8998
              },
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [
            {
              "id": "sp500",
              "symbol": "^GSPC",
              "label": "S&P 500",
              "role": "benchmark",
              "price": 7807.24,
              "base_price": 7811.54,
              "return_since_base_pct": -0.055,
              "session_return_pct": -0.055,
              "as_of": "2026-10-12T20:14:36.141421Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            },
            {
              "id": "nasdaq100",
              "symbol": "^NDX",
              "label": "Nasdaq 100",
              "role": "benchmark",
              "price": 30664.697,
              "base_price": 30883.148,
              "return_since_base_pct": -0.7073,
              "session_return_pct": -0.7073,
              "as_of": "2026-10-12T20:14:36.141421Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            },
            {
              "id": "russell2000",
              "symbol": "^RUT",
              "label": "Russell 2000",
              "role": "benchmark",
              "price": 2795.199,
              "base_price": 2806.9814,
              "return_since_base_pct": -0.4198,
              "session_return_pct": -0.4198,
              "as_of": "2026-10-12T20:14:36.141421Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            }
          ],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 3
          }
        }
      },
      {
        "day": 12,
        "timestamp": "2026-10-12T22:06:16.891160Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-12T22:06:16.891160Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 155.31,
              "base_price": 129.805,
              "return_since_base_pct": 19.6487,
              "session_return_pct": 0.53,
              "change_since_prior_pct": 0.6415,
              "volume_ratio": 0.93,
              "rsi": 93.48,
              "vwap": 153.5,
              "vwap_distance_pct": 1.1792,
              "position_52w_pct": 98.9,
              "extended_hours_pct": 0.0,
              "as_of": "2026-10-12T21:30:11Z",
              "source": "sealed_extended_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "145.43 > 131.47 > 114.13",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-10-12T21:30:11Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 13,
        "timestamp": "2026-10-13T15:27:33.693840Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-13T15:27:33.693840Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 154.58,
              "base_price": 129.805,
              "return_since_base_pct": 19.0863,
              "session_return_pct": -0.47,
              "change_since_prior_pct": -0.47,
              "volume_ratio": 0.13,
              "rsi": 94.42,
              "vwap": 153.09,
              "vwap_distance_pct": 0.9733,
              "position_52w_pct": 98.4,
              "extended_hours_pct": null,
              "as_of": "2026-10-13T14:06:26.349567Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "147.26 > 133.57 > 115.72",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-10-13T14:06:26.349567Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 13,
        "timestamp": "2026-10-13T20:07:58.181308Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-13T20:07:58.181308Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 155.755,
              "base_price": 129.805,
              "return_since_base_pct": 19.9915,
              "session_return_pct": 0.29,
              "change_since_prior_pct": 0.7601,
              "volume_ratio": 0.5,
              "rsi": 95.84,
              "vwap": 154.02,
              "vwap_distance_pct": 1.1265,
              "position_52w_pct": 99.2,
              "extended_hours_pct": null,
              "as_of": "2026-10-13T19:24:51.998952Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "147.49 > 133.67 > 115.76",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-10-13T19:24:51.998952Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 13,
        "timestamp": "2026-10-13T21:45:44.741876Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-13T21:45:44.741876Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 156.97,
              "base_price": 129.805,
              "return_since_base_pct": 20.9275,
              "session_return_pct": 1.07,
              "change_since_prior_pct": 0.7801,
              "volume_ratio": 0.72,
              "rsi": 95.94,
              "vwap": 154.02,
              "vwap_distance_pct": 1.9153,
              "position_52w_pct": 99.6,
              "extended_hours_pct": 0.0,
              "as_of": "2026-10-13T21:23:24Z",
              "source": "sealed_extended_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "147.74 > 133.79 > 115.81",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-10-13T21:23:24Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 14,
        "timestamp": "2026-10-14T14:32:45.863613Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-14T14:32:45.863613Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 149.03,
              "base_price": 129.805,
              "return_since_base_pct": 14.8107,
              "session_return_pct": -5.06,
              "change_since_prior_pct": -5.0583,
              "volume_ratio": 0.14,
              "rsi": 78.75,
              "vwap": 150.04,
              "vwap_distance_pct": -0.6732,
              "position_52w_pct": 94.6,
              "extended_hours_pct": null,
              "as_of": "2026-10-14T14:06:37.850462Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "148.0 > 135.17 > 117.11",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-10-14T14:06:37.850462Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 14,
        "timestamp": "2026-10-14T20:03:58.999644Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-14T20:03:58.999644Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 141.47,
              "base_price": 129.805,
              "return_since_base_pct": 8.9866,
              "session_return_pct": -9.87,
              "change_since_prior_pct": -5.0728,
              "volume_ratio": 0.87,
              "rsi": 67.88,
              "vwap": 145.53,
              "vwap_distance_pct": -2.7898,
              "position_52w_pct": 89.8,
              "extended_hours_pct": null,
              "as_of": "2026-10-14T19:41:13.876792Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "146.48 > 134.48 > 116.82",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-10-14T19:41:13.876792Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 14,
        "timestamp": "2026-10-14T21:41:00.222853Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-14T21:41:00.222853Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 140.55,
              "base_price": 129.805,
              "return_since_base_pct": 8.2778,
              "session_return_pct": -9.86,
              "change_since_prior_pct": -0.6503,
              "volume_ratio": 1.2,
              "rsi": 67.91,
              "vwap": 145.53,
              "vwap_distance_pct": -3.422,
              "position_52w_pct": 89.8,
              "extended_hours_pct": -0.67,
              "as_of": "2026-10-14T21:10:29Z",
              "source": "sealed_extended_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "146.49 > 134.49 > 116.82",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "price_as_of": "2026-10-14T21:10:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 0
          }
        }
      },
      {
        "day": 15,
        "timestamp": "2026-10-15T22:17:29.869958Z",
        "comparison": {
          "schema_version": "public-candidate-comparison.v1",
          "captured_at": "2026-10-15T22:17:29.869958Z",
          "base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
          "source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
          "rows": [
            {
              "symbol": "P",
              "role": "selected",
              "price": 123.88,
              "base_price": 129.805,
              "return_since_base_pct": -4.5645,
              "session_return_pct": 1.641,
              "change_since_prior_pct": -11.8605,
              "volume_ratio": 1.51,
              "rsi": 77.39,
              "vwap": 126.57,
              "vwap_distance_pct": -2.1253,
              "position_52w_pct": 98.82,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:18:46Z",
              "source": "yfinance_quote",
              "name": "Everpure, Inc.",
              "episode_id": "n0:P:2026-09-24",
              "ema_trend": "109.06 > 103.55 > 96.59",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T17:20:13Z",
              "facts": [
                "The sealed investor-day news records reaffirmed FY2027 revenue guidance of $5.03-$5.07 billion and preliminary FY2028 revenue guidance of $7.0-$7.3 billion.",
                "The latest provider trajectory point at 2026-09-24T17:20:13+00:00 was $127.14 and +15.95075% versus the regular previous close. The earlier scan change was +18.38%.",
                "The 20-session return was +23.64% versus +7.09% for XLK, a supplied excess return of +16.55 percentage points.",
                "At the 11:59:59 EDT intraday observation, price was $129.79 and VWAP was $126.57; the captured range position was 0.909."
              ],
              "benchmark_excess_pct": {
                "sp500": 1.3156,
                "nasdaq100": 1.6918,
                "russell2000": 0.2584
              },
              "price_as_of": "2026-09-24T21:18:46Z",
              "vwap_as_of": null
            },
            {
              "symbol": "GRAL",
              "role": "alternative",
              "price": 125.23,
              "base_price": 117.79,
              "return_since_base_pct": 6.3163,
              "session_return_pct": 0.016,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 2.08,
              "rsi": 86.3,
              "vwap": 114.1,
              "vwap_distance_pct": 9.7546,
              "position_52w_pct": 93.27,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:19:29Z",
              "source": "yfinance_quote",
              "name": "GRAIL, Inc.",
              "episode_id": "n0:GRAL:2026-09-24",
              "ema_trend": "93.62 > 85.4 > 78.78",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T17:19:56Z",
              "facts": [
                "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
                "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
                "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
              ],
              "benchmark_excess_pct": {
                "sp500": -0.3094,
                "nasdaq100": 0.0668,
                "russell2000": -1.3666
              },
              "price_as_of": "2026-09-24T21:19:29Z",
              "vwap_as_of": null
            },
            {
              "symbol": "LLY",
              "role": "alternative",
              "price": 1181.89,
              "base_price": 1186.34,
              "return_since_base_pct": -0.3751,
              "session_return_pct": null,
              "change_since_prior_pct": 0.0,
              "volume_ratio": null,
              "rsi": null,
              "vwap": null,
              "vwap_distance_pct": null,
              "position_52w_pct": null,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:11:47Z",
              "source": "yfinance_quote",
              "episode_id": "narrative:LLY:f6f51d01af66427a",
              "selection_as_of": "2026-09-24T17:20:10Z",
              "facts": [
                "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
                "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
                "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
                "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
              ],
              "price_as_of": "2026-09-24T21:11:47Z",
              "vwap_as_of": null
            },
            {
              "symbol": "UXIN",
              "role": "alternative",
              "price": 1.2983,
              "base_price": 1.2403,
              "return_since_base_pct": 4.6763,
              "session_return_pct": -0.1308,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 59.87,
              "rsi": 59.65,
              "vwap": 1.28,
              "vwap_distance_pct": 1.4297,
              "position_52w_pct": 28.94,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:07Z",
              "source": "yfinance_quote",
              "name": "Uxin Limited",
              "episode_id": "n0:UXIN:2026-09-24",
              "ema_trend": "1.13 > 1.15 > 1.28",
              "vwap_state": "below",
              "selection_as_of": "2026-09-24T15:57:59.818098Z",
              "facts": [
                "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
                "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
                "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
                "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
              ],
              "benchmark_excess_pct": {
                "sp500": -0.4562,
                "nasdaq100": -0.08,
                "russell2000": -1.5134
              },
              "price_as_of": "2026-09-24T21:20:07Z",
              "vwap_as_of": null
            },
            {
              "symbol": "KLXE",
              "role": "alternative",
              "price": 1.4799,
              "base_price": 1.655,
              "return_since_base_pct": -10.5801,
              "session_return_pct": 0.6735,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.42,
              "rsi": 67.09,
              "vwap": 1.6,
              "vwap_distance_pct": -7.5063,
              "position_52w_pct": 37.22,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:14:26Z",
              "source": "yfinance_quote",
              "name": "KLX Energy Services Holdings, Inc.",
              "episode_id": "n0:KLXE:2026-09-24",
              "ema_trend": "1.54 > 1.57 > 1.77",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T16:00:11.989006Z",
              "facts": [
                "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
                "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
                "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
              ],
              "benchmark_excess_pct": {
                "sp500": 0.3481,
                "nasdaq100": 0.7243,
                "russell2000": -0.7091
              },
              "price_as_of": "2026-09-24T21:14:26Z",
              "vwap_as_of": null
            },
            {
              "symbol": "TSSI",
              "role": "alternative",
              "price": 10.19,
              "base_price": 10.1595,
              "return_since_base_pct": 0.3002,
              "session_return_pct": 9.48,
              "change_since_prior_pct": 0.0,
              "volume_ratio": 1.79,
              "rsi": 74.13,
              "vwap": 10.01,
              "vwap_distance_pct": 1.7982,
              "position_52w_pct": 46.62,
              "extended_hours_pct": null,
              "as_of": "2026-09-24T21:20:24Z",
              "source": "yfinance_quote",
              "name": "TSS, Inc.",
              "episode_id": "n0:TSSI:2026-09-24",
              "ema_trend": "8.98 > 8.89 > 9.44",
              "vwap_state": "above",
              "selection_as_of": "2026-09-24T15:59:47.064383Z",
              "facts": [
                "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
                "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
                "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
                "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
              ],
              "benchmark_excess_pct": {
                "sp500": 9.1546,
                "nasdaq100": 9.5308,
                "russell2000": 8.0974
              },
              "price_as_of": "2026-09-24T21:20:24Z",
              "vwap_as_of": null
            }
          ],
          "benchmarks": [
            {
              "id": "sp500",
              "symbol": "^GSPC",
              "label": "S&P 500",
              "role": "benchmark",
              "price": 7744.06,
              "base_price": 7718.94,
              "return_since_base_pct": 0.3254,
              "session_return_pct": 0.3254,
              "as_of": "2026-10-15T22:08:16.381088Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            },
            {
              "id": "nasdaq100",
              "symbol": "^NDX",
              "label": "Nasdaq 100",
              "role": "benchmark",
              "price": 29935.594,
              "base_price": 29950.816,
              "return_since_base_pct": -0.0508,
              "session_return_pct": -0.0508,
              "as_of": "2026-10-15T22:08:16.381088Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            },
            {
              "id": "russell2000",
              "symbol": "^RUT",
              "label": "Russell 2000",
              "role": "benchmark",
              "price": 2767.2693,
              "base_price": 2729.5312,
              "return_since_base_pct": 1.3826,
              "session_return_pct": 1.3826,
              "as_of": "2026-10-15T22:08:16.381088Z",
              "source": "yfinance.ticker_info",
              "base_definition": "previous regular close"
            }
          ],
          "coverage": {
            "candidate_rows": 6,
            "candidate_prices": 6,
            "candidate_technical": 5,
            "benchmark_rows": 3
          }
        }
      }
    ],
    "candidates": [
      {
        "symbol": "GRAL",
        "name": "GRAIL, Inc.",
        "exchange": "NASDAQ",
        "tradingview_url": "https://es.tradingview.com/chart/?symbol=NASDAQ%3AGRAL&interval=60",
        "score": null,
        "price": 117.79,
        "change": null,
        "volume": 1660092,
        "avg_volume_3m": 796334,
        "volume_ratio": 2.08,
        "rsi": 86.3,
        "ema_trend": "93.62 > 85.4 > 78.78",
        "position_52w_pct": 93.27,
        "vwap": 114.1,
        "vwap_distance_pct": null,
        "vwap_state": "below",
        "facts": [
          "The supplied news reports that FDA advisers voted in favor of Galleri; an advisory vote is not final FDA approval.",
          "The latest provider trajectory point at 2026-09-24T17:19:56+00:00 reported +8.542209%. The earlier captured intraday observation was below its then-observed $114.10 VWAP.",
          "The 20-session return was +42.45% while the healthcare ETF proxy returned -3.26%, for a supplied excess return of +45.71 percentage points.",
          "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $40.785 million revenue, with revenue growth of 28.105663% year over year, and a $93.187 million net loss."
        ],
        "role": "alternative",
        "selected": false,
        "reason": "not_selected"
      },
      {
        "symbol": "LLY",
        "name": "",
        "exchange": "NYSE",
        "tradingview_url": "https://es.tradingview.com/chart/?symbol=NYSE%3ALLY&interval=60",
        "score": null,
        "price": 1186.34,
        "change": null,
        "volume": 1271906.0,
        "avg_volume_3m": 2667658.0,
        "volume_ratio": null,
        "rsi": null,
        "ema_trend": null,
        "position_52w_pct": null,
        "vwap": null,
        "vwap_distance_pct": null,
        "vwap_state": null,
        "facts": [
          "One trusted-reporting item says Lilly received FDA approval for weekly insulin Onswik and signed a $3.25 billion InnoCare pact; the supplied candidate packet contains no direct issuer or regulator record for those current claims.",
          "Three provider observations ranged from +3.0434694% to +3.1720529%; a normalized daily change and VWAP observation were unavailable.",
          "The captured 20-session asset return was -3.85%, and the accumulation/distribution reading was labeled distribution.",
          "The SEC prepared snapshot is dated 2026-09-01 and covers a quarter ended 2026-03-31."
        ],
        "role": "alternative",
        "selected": false,
        "reason": "not_selected"
      },
      {
        "symbol": "UXIN",
        "name": "Uxin Limited",
        "exchange": "NASDAQ",
        "tradingview_url": "https://es.tradingview.com/chart/?symbol=NASDAQ%3AUXIN&interval=60",
        "score": 8,
        "price": 1.2403,
        "change": 13.73,
        "volume": 14687157,
        "avg_volume_3m": 245331,
        "volume_ratio": 59.87,
        "rsi": 59.65,
        "ema_trend": "1.13 > 1.15 > 1.28",
        "position_52w_pct": 28.94,
        "vwap": 1.28,
        "vwap_distance_pct": null,
        "vwap_state": "below",
        "facts": [
          "The sealed news records Q2 sales of $169.664 million versus $70.853 million in the year-earlier report and Q3 sales guidance of $170.963-$175.384 million.",
          "The captured scan change was +13.73% on 59.87 times average volume; the 30-minute observation was below the $1.28 VWAP with range position 0.331.",
          "The SEC transaction summary classifies a 104,931,794-share Form 4 transaction as an open-market purchase, equal to 162.3577% of the supplied float.",
          "The prepared SEC fundamentals show a latest quarter ending 2024-03-31 and limited current-quarter coverage."
        ],
        "role": "alternative",
        "selected": false,
        "reason": "not_selected"
      },
      {
        "symbol": "KLXE",
        "name": "KLX Energy Services Holdings, Inc.",
        "exchange": "NASDAQ",
        "tradingview_url": "https://es.tradingview.com/chart/?symbol=NASDAQ%3AKLXE&interval=60",
        "score": 5,
        "price": 1.655,
        "change": 12.59,
        "volume": 705454,
        "avg_volume_3m": 498507,
        "volume_ratio": 1.42,
        "rsi": 67.09,
        "ema_trend": "1.54 > 1.57 > 1.77",
        "position_52w_pct": 37.22,
        "vwap": 1.6,
        "vwap_distance_pct": null,
        "vwap_state": "above",
        "facts": [
          "An SEC 8-K records adoption of a limited-duration rights plan after rapid accumulation by a new investor.",
          "The captured scan change was +12.59%; the intraday observation was above the $1.60 VWAP, with range position 1.0.",
          "The 20-session return was +11.82% versus +0.74% for the energy ETF proxy, a supplied excess return of +11.08 percentage points.",
          "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $144.7 million revenue, down 6.038961% year over year, a $24 million net loss, $271.3 million noncurrent debt, and $5.6 million cash."
        ],
        "role": "alternative",
        "selected": false,
        "reason": "not_selected"
      },
      {
        "symbol": "TSSI",
        "name": "TSS, Inc.",
        "exchange": "NasdaqCM",
        "tradingview_url": "https://es.tradingview.com/chart/?symbol=NASDAQ%3ATSSI&interval=60",
        "score": 3,
        "price": 10.1595,
        "change": 9.48,
        "volume": 1542580,
        "avg_volume_3m": 863063,
        "volume_ratio": 1.79,
        "rsi": 74.13,
        "ema_trend": "8.98 > 8.89 > 9.44",
        "position_52w_pct": 46.62,
        "vwap": 10.01,
        "vwap_distance_pct": null,
        "vwap_state": "above",
        "facts": [
          "The captured scan change was +9.48% on 1.79 times average volume; the intraday observation was above the $10.01 VWAP.",
          "The 20-session return was +21.48% versus +7.09% for the technology ETF proxy, a supplied excess return of +14.39 percentage points.",
          "The attached current news item is a generic technology-stock roundup, not a TSSI-specific event.",
          "The SEC prepared snapshot for the quarter ended 2026-03-31 reports $55.346 million revenue and a supplied year-over-year revenue change of -44.071787%."
        ],
        "role": "alternative",
        "selected": false,
        "reason": "not_selected"
      }
    ],
    "news": [
      {
        "title": "SEC 8-K filing",
        "url": "https://www.sec.gov/Archives/edgar/data/1474432/000147443226000084/pstg-20260826.htm"
      }
    ],
    "transcript_url": null,
    "initial_transcript_anchor": "transcript-entry-959e8b2b32010f380b99b568ac7a0f8a4a95982171869d4eca27145b2e95d854",
    "chart_url": null,
    "secondary_chart_url": null,
    "forecast_chart_url": null,
    "methodology_url": "https://trydingday.com/methodology/",
    "track_record_url": "https://trydingday.com/track-record/",
    "market_timezone": "America/New_York"
  }
}